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1-1 "Mycoplasma Infectious Diseases, MIDs"  
  
   Mycoplasmas, the smallest free-living organisms known, are 
prokaryotes that are bounded only by a plasma membrane.
（Figure 1-1）. Their lack of a cell wall provides for direct and 
intimate contact of plasma membrane with the cell surface of the 
host cell. Therefore, under appropriate conditions, it may cause 
cell fusion and then infect host cell. （Figure 1-2）. This special 
structure is associated with cellular pleomorphism and 
resistance to cell wall-active antimicrobial agents such as 
penicillins and cephalosporins.. The organisms’ small genomes 
limit biosynthesis and explain the difficulties encountered with 
in vitro cultivation.    
 
 
Figure 1-1. Mycoplasma is a “plasma”-like form without cell wall. 
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   Mycoplasmas typically colonize mucosal surfaces of the 
respiratory and urogenital tracts of many animal species. 
Sixteen species of mycoplasmas have been recovered from 
human M. pneumoniae causes upper and lower respiratory 
infections. M. genitalium and Ureaplasma urealyticum are 
established causes of urethritis and have been implicated in 
other genital conditions[1]. 
 
 
Figure 1-2. The fusion of mycoplasma with eukaryotic host cell and it may 
causes mycoplasma infectious diseases（MIDs）. 
 
    Mycoplasmas are well known as the pathogens of 
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mycoplasma pneumonia, and have also come to be recognized as 
causative bacterias in asthma, rheumatic diseases and 
neurological disorders [2-5]. Also it is suspected that 
mycoplasmas are related to atherosclerosis and tumours 
(including leukaemia) [6.7]. The concept of mycoplasma-caused 
infectious diseases has changed to include not only pneumonia 
but also other serious illness, now termed mycoplasma-related 
disorders. 
   Mycoplasma Infectious Diseases (MID) are systemic illnesses 
that cause vasculitis and neuritis. MID not only includes 
pneumonia but also diseases such as asthma, arthritis, 
nephritis, meningitis, encephalitis, dermatitis, pancreatitis, 
hepatitis, and hematologic illnesses. The broader concept of 
MID encompasses acute to chronic phases with diverse 
symptoms. Therefore, it is often confusing and difficult to 
identify Mycoplasma-infected patients among those with 
incurable diseases, such as autoimmune diseases, rheumatic 
diseases, nervous system disorders, and hematological disorders. 
(Table1-1) 
    In brief， it is confusing and difficult to identify the 
mycoplasma-infected patient among those of incurable diseases, 
 9 
such as autoimmune diseases, a rheumatic disease, a nervous 
system disorder, and hematological disorders. 
   Therefore, it is important to know the cause of it as early as 
possible to avoid it. In the case of the new diagnostics for 
mycoplasma enable it to see the state of infection at the time of 
asymptomatic infection. Incubation periods can be decades 
before symptoms appear. It is very important issue, the control 
and prevention for infection from mothers to infants. 
 
Table1-1. Species that infect humans and associated diseases 
 
Species       Associated Diseases  
M.amohoriforme Chronic bronchopneumonia[8] 
M. fermentans  
Respiratory, genital and  
   rheumatoid diseases [9]and AIDs[10] 
M. genitalium Male urethritis[10] 
M. pirum   Isolated from a few AIDs patients[10] 
 
 
M. pneumonia     
Subclinical infection, upper respiratory  
disease, bronchopneumonia[10]and central  
    nervous system diseases[11] 
M. salivarium Periodontal diseases[12] 
M. hominis    Genital infections in the adult[13] 
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1-2 Antigenic properties of mycoplasma out-member 
   
Mycoplasmas have surface antigens such as membrane 
proteins, lipoproteins, lipoglycans and glycolipids.(Figure1-3)  
Membrane proteins have several different topologies and 
perform a variety of fuctions vital to the survival of organism, 
such as relay signals between the cell’s internal and external 
environments , oxidoreductase , transferase or allow cells to 
identify each other. Lipoproteins serve to emulsify the lipid 
molecules. Lipoglycans can determine cell-environment 
interactions. 
 
 
Figure1-3. Antigenic properties of Mycoplasma out-member 
 
   Glycolipids constitute a significant portion of membrane lipid 
in several mycoplasmas. Some studies had indicated that 
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monoglycosyldiacylglycerol and diglycosyldiacylglycerol are two 
majoy glycolipids on the surface of mycoplasma member, where 
their nonbilayer-bilayer balance contributes to membrane 
properties such as curvature and stability, as shown in 
Acholeplasma laidlawii, one of the best investigated bacteria 
with regard to the function of glycolipids  in biological  
membranes. In addition, free glycoglycerolipids (GGLs) isolated 
form Mycoplasma out-member as structural elements play a 
fundamental role in membrane properties and stability. [14-16] 
GGLs are not only key structural components of the plasma 
membrane in mycoplasmas, but also active lipid components of 
M.pneumoniae. (Figure 1-4) 
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Figure 1-4. GGL glycolipid antigens isolated from M.pneumoniae 
 
1-3 Glycolipids and Innate Immunity  
   
   Glycolipids are reported that they are closed related to 
immune responses. The human immune system is constantly 
exposed to a great variety of microorganisms and other 
antigenic substances. Microorganisms invading the body are 
attacked by primary immune responses (such as the 
complement system) or phagocytosis by macrophages or 
neutrophils. 
    Bacterial cell walls are major targets of host immune 
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responses. Lipids are major components of biomembranes. 
Microbial lipopolysaccharides are located on the surface of 
biomembranes and are important in the host recognition of 
microbial infections and subsequent immune responses.  
   Until recently, it had been the paradigm that T cells 
recognize peptide antigens that are presented by major 
histocompatibility complex (MHC) class I or I molecules. It has 
now been demonstrated that lipids can be presented by antigen 
-presenting cells (APC) through the CD1 family of molecules. 
The structures of the CD1 family of molecules are similar to 
those of MHC class I and II molecules.  
   Lipid and glycolipid antigens include naturally occurring 
foreign glycolipids from intracellular pathogens and synthetic 
glycolipids that are related in structure to mammalian 
glycolipids. The portals and pockets of CD1 antigen-binding 
grooves influence ligand specificity and facilitate presentation of 
a surprisingly diverse set of antigenic lipids, glycolipids, 
lipopeptides and even some small, non-lipidic molecules. 
Presentation of antigens by CD1 proteins requires uptake and 
intracellular processing by APCs. There is evidence for the 
existence of cellular pathways that lead to presentation of both 
 14 
exogenous and endogenous lipid antigens. [17-19] 
αGalCer-α-glycolipids have been identified and its 
commonly used form comprises an α-linked galactose head 
group and a ceramide base (consisting of an 18-carbon phyto- 
sphingosine chain and a 26-carbon acyl chain). Subsequently, 
hydrophobic tail of αGalCer was shown to bind to human and 
mouse CD1d and potently activate type I NKT cells.  [20] In 
addition to this, hydrophilic head of glycolipids can be 
recognized by NKT cell and activate them to release Th1 and 
Th2 .(Figure 1-5) 
Figure 1-5. CD1d‐mediate glycolipids antigen (αGalCer) presentation. 
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1-4   Glycolipids and "MIDs" 
 
   It is thought that the lipid antigens of the cell membrane of 
mycoplasmas play an important role in the immune response, 
and that the cell membrane is in direct contact with the external 
world. The proteins and lipids of mycoplasma membranes are 
the main immunogens and antigens that are recognized by 
anti-mycoplasma sera. Both proteins and lipids play a major 
role in growth and metabolic inhibition tests for mycoplasmas. 
Glycolipids play a main role in the assay for the M. pneumoniae 
and M. fermentans complement binding assays. [21] 
   As a solution to the problem of a lack of antigen, small 
antigenic molecules of mycoplasmas have been found to be 
lipid-antigens. The structures of the mycoplasma lipid-antigens 
were then determined and chemically synthesized. M. 
fermentans has specific lipid-antigens called GGPL-I and 
GGPL-III, and M. pneumoniae also has specific lipid-antigen 
GGL moieties. [22-26] The complete structures of the 
immunodeterminants of glycolipid antigens have been 
determined using instrumental analyses including nuclear 
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magnetic resonance, mass spectrometry and chemical 
syntheses. 
1-4.1 M. fermentans lipid-antigens phosphocholine-containing 
glycoglycerolipids (GGPLs) 
 
   Recently, evidence has accumulated that M. fermentans is a 
pathogen of rheumatoid arthritis (RA). M. fermentans has 
frequently been isolated from the synovial fluid of patients with 
rheumatoid arthritis, and exhibits agglutinating activity 
towards erythrocytes. Moreover, M. fermentans has been shown 
to induce experimental arthritis in rabbits following inoculation 
of the trachea and knee joint. [27] 
   GGPLs, which have strong antigenicity and are 
species-specific immunological determinants of M. fermentan [28], 
surprisingly have characteristic phosphocholine-containing 
glycoglycerolipids and can be clearly distinguished from other 
human related mycoplasma species through lipid analysis. 
Phylogenetic data strongly support the notion that mycoplasma 
species evolved from ancestors that are common to 
Gram-positive bacteria. This potential relationship suggests 
that it would be interesting to examine the distribution of GGPL 
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in other microorganisms, as these lipid antigens are synthesized 
with specific enzymes [29,30]. 
    A monoclonal antibody that specifically recognizes 
GGPL-III could detect the existence of the GGPL-III antigens in 
synovial tissues from RA patients. GGPL-III antigens were 
detected in 38.1% (32/84) of RA synovial tissues, but not in 
osteoarthritis (OA) or normal synovial tissues[31]. Interestingly, 
GGPL-III antigens were detected on the surface of the 
endoplasmic reticulum by electron microscopic analysis in the 
GGPL-III antigen positive synovial tissue. Since it has been 
reported that lipid-antigens are presented by CD1 molecules 
through the endoplasmic reticulum, the mycoplasma 
lipid-antigen might be presented by such a mechanism. 
 
1-4.2 M.pneumoniae lipid-antigens GGLs  
(GGL Gal-type and GGL Glc-type) 
 
    M. pneumoniae is a leading pathogen of both upper and 
lower human respiratory infections. Mycoplasma pneumonia, 
known as the cause of “primary atypical pneumonia”, is 
sometimes accompanied by other clinical syndromes: 
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Stevens-Johnson syndrome, nephritis (including IgA nephritis), 
autoimmune haemolytic anaemia, meningoencephalitis, GBS 
and acute psychosis. Cold agglutinin anti-I antibodies are found 
in the serum of as many as 70% of patients with mycoplasma 
pneumonia. The immunogenicity of M. pneumoniae is thought 
to be mainly due to membrane glycolipids. Mycoplasma 
lipid-antigens are useful biomarkers for induced levels of 
antibodies, and are superior in specificity and sensitivity to 
conventional biomarkers. 
 
1-5 Purposes of this research 
 
   Today, diagnosis of mycoplasma infectous diseases（MIDs） is 
carried out by X-ray radiograph, culture, 
antigen-amplification(PCR), direct antigen detection by 
immunofluorescence or detection of cold agglutinin. However, 
there is no straightforward method that is valid at an early 
stage in infection and appearance of the pneumonia symptoms. 
    Among various mycoplasma surface antigens, glycolipid is 
closely related to pathology of mycoplasma. Just recently, 
Matsuda et al. [32].found out the presence of a pair of -glycolipid 
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antigens in the cell-membrane components of the M. 
pneumoniae. One is -D-galactopyranosyl-(1→6)--D 
-galactopyranoside (-Gal-type1) and another -D- 
glucopyranosyl -(1→6)-- D-galactopyranoside(-Glc-type2). 
Miyachi et al. [26] have already performed stereoselective 
syntheses of each -glycolipid antigens. (C16:0 fatty acid 
homologues) 
   Structural analysis of synthetic glycolipid antigens is critical 
for understanding the mechanisms of molecular interactions 
involved in the pathogenesis of immune abnormalities, and for 
devising strategies surrounding immune system regulation and 
drug discovery.  
   This study aims at developing an effective diagnostic 
methodology of mycoplasma infectious diseases (MIDs). Present 
study has already tried to utilize synthetic glycolipid antigens. 
In this thesis, two different species of mycoplasma synthetic 
glycolipid antigens have been chemically synthesized and fully 
characterized with proton NMR spectroscopy， respectively. 
Every diastereomeric proton (HproR and HproS protons) was 
discriminated and subjected to conformational analysis based on 
Karplus equations. 
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1-6 Synthesis of mycoplasma glycolipid antigens 
 
Glycolipids are present in outer surface of plasma membrane in forms 
of either glycerolglycolipids or sphingoglycolipids. Glyceroglycolipids consist 
of a mono- or oligosaccharide moiety linked glycosidically to the hydroxyl 
group of glycerol.  Sphingoglycolipids are formed by head group to 
ceramide. Glycolipids are amphiphilic, meaning they may serve as 
important building blocks of biomembranes. Natural glycolipids are 
lipids with a carbohydrate attached and usually occur as 
complex mixtures, so it is very difficult to separation of a 
homogeneous molecular species. Thus, chemical synthesis of 
glycolipids play an important role in study of their biological 
functions. Recently, a lots of synthetic studies are reported for 
glycolipids. Base on purpose of this study, syntheic mycoplasma 
glycolipid antigens have much attracted a strong attention. 
   Regarding chemical syntheses, for GGLs ，it contains formation of 
glucose ,galatose and glycerols .(Figure 1-6) Miyachi et al. [31] have 
accomplished stereoselective synthesis M. pneumoniae -glycolipids by 
using non-malodorous thio-glycosylation method. The synthetic products 
confirm the absolute stuctures of the natural products.（Figure 1-7） 
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Figure 1-6. Synthesis of glycolipids starts with the different formations led to a glucose or 
galactose residue, respectively. 
 
 
 
 
 
Figure 1-7. Synthesis M. pneumoniae -glycolipids by using 
non-malodorous  thio-glycosylation method. 
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1-7 Synthetic glycolipid antigens for diagnosis of MIDs by 
ELISA 
 
   Early diagnosis of M.pneumonie infection is important to 
prevent because of the appearance of antibiotics resistant 
mycoplasma, and also from the viewpoint of medical economics 
New ELISA which utilize chemically synthesized 
mycoplasma species-specific lipid-antigen (anti- GGL Glc-type 
ELISAs ) are superior to conventional methods. 
    In child patients, the anti-GGL Glc-type ELISA (IgM ) is 
much more suitable for the rapid early diagnosis of M 
pneumoniae infection than currently available conventional 
serological methods, and also anti-GGL Glc-type ELISA (IgG ) 
reflect the status of infection. 
    In adult patients, the anti-GGL Glc-type ELISAs (IgM 
/IgG/IgA) are available to diagnose M. pneumoniae infection 
suitable for the early diagnosis of M.pneumoniae infection and 
follow the clinical course quantitatively 
    The anti-GGL Glc-type ELISAs enable the studies for the 
links to chronic diseases, extrapulmonary diseases, and possibly 
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M. pneumoniae infection-related disease, such as asthma 
rheumatoid arthritis. 
 
1-8 Summary of this thesis 
 
Anti-lipid antigen antibodies are specific and quantitative 
markers of mycoplasma infection. Mycoplasma infected and 
non-infected patients among each disordes, such as asthma, 
multiple sclerosis, could be selected , and estimated the effect of 
each drug. Mycoplasma lipid-antigens are a useful tool for the 
understanding molecular mechanism of chronic inflammatory 
diseases, and for devising strategies for regulation of the 
immune system and for drug discovery. 
   In chapter 2 described a practical synthetic pathway to 
GGPL-I homologue (C16:0) and its diastereomer, in which our 
one-pot -glycosylation method was effectively applied. A 
common conformational property of GGPL-I and DPPC. The tail lipid 
moiety favors two gauche-conformers of gt and gg (gt > gg >> tg), while the 
head moiety takes three conformers in averaged populations (gt = gg = tg). 
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   In chapter 3 described comparative analyses of helical 
property in asymmetric 1,2-di-O-acyl-sn-glycerols by means of 
1H NMR and circular dichroic (CD) spectroscopy: Notable effects 
of substituting groups at sn-3 position. 
   In chapter 4 described a conformational analysis for a series 
of 1,2-di-O-palmitoyl-sn-glycerols carrying different functional 
groups at the sn-3 position. 
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2-1 Introduction 
 
   Mycoplasmas constitute a family of gram-positive microbes lacking rigid 
cell walls. They are suspected to associate with human immune diseases in 
either direct or indirect ways, though the molecular mechanism is not fully 
understood[1]. In recent biochemical studies, Mycoplasma outer-membrane 
lipoproteins[2,3] and glycolipids[4-6] are thought to serve not only as the main 
antigens but also as probable pathogens. Also in our research team, 
Matsuda et al. [7-10] has isolated a new class of -glycolipid antigens (GGPL-I 
and GGPL-III, Figure 2-1) from M. fermentans. Another -glycolipid (Mf 
GL-II), which has a chemical structure very close to GGPL-III, was 
identified and characterized by other groups [12-14].  
     Absolute chemical structures of GGPL-I [15] and GGPL–III [16] have 
already been established by chemical syntheses of stereoisomers; these 
-glycolipids have a common chemical backbone of 3-O-(-D- 
glucopyranosyl) -sn-glycerol carrying phosphophocholine at the sugar 
primary (6-OH) position. The fatty acids at the glycerol moiety are 
saturated [palmitic acid (C16:0) and stearic acid (C18:0)]. GGPL-I has a 
structural feature. 
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Figure 2-1: Absolute chemical structures of M. fermentans -glycolipid antigens, GGPL-I 
and GGPl-III (GGPL: Glycosyl-sn-glycerophospholipid). 
 
analogous to 1,2-di-O-palmitoyl phosphatidylcholine (DPPC) as a 
ubiquitous  cell membrane phospholipid. Apparently, GGPLs are of 
amphiphilic compounds which can form certain self-assembled structures 
under physiological conditions[12,13] and may give physicochemical stress on 
the host immune cell systems [17]. Actually, our research team has proven 
that these -glycolipid antigens have certain pathogenic functions[18,19].  
    In order to exploit their biological functions in detail, it is necessary to 
obtain these -glycolipids in sufficient amounts. Thus, both genetic [20-22] and 
chemical synthetic approaches [23,24] are being undertaken, whereas no 
practical way has been established yet.  In this paper, we report a chemical 
access to both natural GGPL-I homologue (C16:0) and its diastereomer (I-a 
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and I-b in Scheme2-1), in which our one-pot -glycosylation methodology 
[25,26] is effectively applied. The two GGPL-I isomers prepared thereby were 
characterized with 1H NMR spectroscopy in terms of configuration and 
conformation at the asymmetric glycerol moiety. 
 
2-2 Result and Discussion 
 
A practical synthetic access to GGPL-I homologues 
   GGPL-I provides two key asymmetric centers to be controlled literally in 
the synthetic pathway. One is the configuration at the chiral glycerol moiety, 
and another is the sugar -glycoside linkage. In former synthetic works on 
3-O-(-D-glycopyranosyl)-sn-glycerol [27-30], chiral 1,2-O-isopropylidene- 
sn-glycerol is often employed [29,30] as the acceptor substrate of different 
-glycosylation reactions. In this case, however, an attention should be paid 
to the acid catalyzed migration of the dimethylketal group [23,29,30,31]. In our 
synthetic pathway, chiral (S)- or (R)-glycidol is employed as an alternative 
source of the chiral glycerol to circumvent this problem.  
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Scheme 2-1. An established synthetic pathway to -glycosyl-sn-glycerols 4a and 5a. A 
reagent combination of CBr4 and Ph3P (Appel-Lee reagent) is utilized in either CH2Cl2 or 
DMF solvent.  
 
    In an established synthetic approach, 6-O-acetyl-2,3,4-tri-O-benzyl 
protected sugar 1 [23] is used as the donor and treated with a reagent 
combination of CBr4 and Ph3P (Appel-Lee reagent) in either CH2Cl2 or 
DMF solvent (or their mixture). For the reaction in CH2Cl2, 
N,N,N’,N’-tetramethylurea (TMU) is added after in situ formation of 
-glycosyl bromide 2 which equilibrates with a more reactive-glycosyl 
bromide species [32]. In the pathway using DMF, the -glycosylation is 
routed by -glycosyl cationic imidate 3 which was predicted in formers 
studies [33] and evidenced in our preceding NMR and MS study [25,26].  
The reaction between 1 and (S)-glycidol in CH2Cl2 (+TMU) gave a 
mixture of epoxy compound 4a (60~70%) and bromide 5a (30-40%). In 5a, 
the oxirane ring was opened by nucleophilic Br- ions produced by Ph3P and 
CBr4. Also in the DMF-promoted reaction, a mixture of 4a (70~90%) and 5a 
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(10~30%) was derived. In both reaction pathways, however, the 
glycosylation was -selective ( = >90:10, yields >80%) and not 
accompanied by isomerization at the glycerol moiety.  
A mixture of 4a and 5a was used in the following chemical 
transformation (Scheme 2). First, a lyso-glycolipid 6a was derived after 
de-protection at the sugar hydroxymethyl position and SN2 substitution 
with cesium palmitate at the glycerol sn-1 position. Then, this compound 
was converted to  glycolipid 8a after the sequential reactions of temporary 
protection at the sugar primary position with tbutyldimethylsilyl group 
(TBDMS), O-acylation at the glycerol 2-OH position to give 7a, and then 
removal of the TBDMS group.  
    For introducing phosphocholine group at the sugar 6-OH position, we 
employed a phosphoroamidite method using 1H-tetrazole as promoter [34]. 
First, 8a was treated with 2-cyanoethyl-N,N,N’,N’-tetraisopropyl 
phosphorodiamidite in the presence of 1H-tetrazole and then with choline 
tosylate to give 9a. After de-protection of the sugar O-benzyl group by 
catalytic hydrogenolysis, GGPL-I homologue I-a was obtained. In the 
same way, the GGPL-I sn-isomer I-b was derived from a mixture of 4b and 
5b available in the reaction between 1 and  (R)-glycidol  (Schemes 2-1 and 
2-2b).  
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Scheme2-2: Syntheses of GGPL-I homologue I-a and its isomer I-b. Conditions: Conditions: 
a) K2CO3, CH3OH; b) cesium palmitate in DMF; c) TBDMS chloride then 
palmitoyl chloride in pyridine + DMAP; d) TFA in  CH3OH; e) i) 
2-cyanoethyl-N,N,N’,N’-tetraisopropyl phosphorodiamidite, 1H-tetrazole and MS-4A in 
CH2Cl2; ii) choline tosylate, 1H-tetrazole, iii) mCPBA, iv) aq. NH3 in CH3OH, f) H2, 
Pd(OH)2/C in CH3OH . 
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1H NMR characterization of I-a, I-b and the related glycerolipids  
1H NMR spectroscopy provides a useful tool for discriminating 
between the two GGPL-I isomers as shown in Figure 2: A clear difference 
was observed in chemical shifts of glycerol methylene protons as 
designated with “a” and “b”. Conversely, little difference was observed 
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between the sn-isomers at the sugar H-1 signal as well as at the glycerol 
H-2 (Table 2-1). Natural GGPL-I and GGPL-III gave 1H NMR data very 
close to those of I-a, indicating that both have a common skeleton of 
3-O-(-D-glucopyranosyl)-sn-glycerol [15,16]. 
 
 
 
Figure2-2: 1H-NMR spectra of I-a and I-b (5OOMHz, 25℃, CDCl3:CD3OD=10:1). 
Assignment of sn-glycerol methylene protons (HproR and HproS) was performed on the basis 
of our preceding studies on deuterium-labeled glycerols [35-37] -6)-linked 
disaccharides[38-40] 
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Table2-1. 1H-NMR data (500MHz) of I-a, I-b, and their precursors (9a and 9b).  
 
  ppm  ( 3J and 2JHz ) 
Comp. glucose  sn-glycerol moiety 
 H-1’  H-1 H-2 H-3 
    proR            proS proR proS 
        
I-a  4.80 
(3.5) 
 4.14 
(6.5) 
4.40 
(3.5,12.0) 
5.24 3.76 
(5.5) 
3.61 
(5.5,11.0) 
        
9a  4.70 
(3.5) 
 4.17 
(6.5) 
4.38 
(3.0,12.0) 
5.22 3.72 
(5.5) 
3.52 
(6.0,11.0) 
        
        
I-b  4.80 
(3.5) 
 3.80 
(6.0) 
3.57 
(5.5,11.0) 
5.23 4.34 
(3.5) 
4.20 
(6.5,12.0) 
        
9b  4.74 
(3.5) 
 3.76 
(5.5) 
3.57 
(5.5,11.0) 
5.23 4.37 
(3.0) 
4.19 
(6.5,12.0) 
        
These -glycolipids were dissolved in a mixture of CDCl3 and CD3OD (10:1) 
at 11.2mM concentration.  
 
    The glycerol moiety has two C-C single bonds. By free rotation, each of 
them is allowed to have three staggered conformers of gg (gauche-gauche), 
gt (gauche-trans) and tg (trans-gauche) (Figure 2-3). In solution and also in 
self-contacting liquid crystalline states, these conformers are thought to 
equilibrate each other. In this study, we calculated time-averaged 
populations of the three conformers by means of 1H NMR spectroscopy. As 
we reported in a preceding paper [41], the Karplus-type equation proposed 
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by Haasnoot et al.[42] was adapted for the formulation of Equation-1:  
 
Equation-1 
       2.8gg + 3.1gt + 10.7tg = 3JH2,H1S （or  3JH2,H3R） 
       0.9gg + 10.7gt + 5.0tg = 3JH2,H1R （or 3JH2,H3S） 
           gg + gt + tg = 1 
 
    In this equation, a perfect staggering (1 and 2 = +60, -60 or 180 
degree) is assumed for every conformer. Figure 3 summarizes the results 
for a series of 3-substituted 1,2-di-O-palmitoyl-sn-glycerols, which involve 
tripalmitin (entry 1), DPPC (1,2-di-O-palmitoylphosphatidylcholine) (entry 
2), and GGPL-I homologues (entries 3-5). In a solution state using a 
mixture of CDCl3 and CD3OD (10:1) as the solvent and concentration at 
11.2mM, tripalmitin adopts the three conformers in ratio of gt(45%), 
gg(37%) and tg(17%). In comparison with this symmetric lipid, the 
asymmetric phospholipid (DPPC) favors gt-conformer more strongly 
around the tail lipid moiety along sn-1,2 position, while disfavoring 
tg-conformer in the ratio of gt(59%), gg(34%) and tg(7%). The head 
phosphate moiety along sn-2,3 position adopts the three conformers in 
averaged populations (gg=gt=tg).  
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Figure 2-3.  Distributions of gg, gt and tg-conformers in 3-substituted sn-glycerols at 11 
mM solutions in CDCl3 and CD3OD (10:1) at 298K.  
 
    3-O-(-D-glucopyranosyl)-sn-glycerolipids 10 and 11 (entries 3 and 4) 
were found to have a conformational property very similar to DPPC; the 
lipid tail moiety prefers the gauche conformations (gt and gg), while the 
sugar moiety allows a random conformation. Here, it should be mentioned 
that the conformer distribution coincidences between I-a (entry 5) and 
DPPC (entry 1) at the tail moiety [gt(33%), gg(34%) and tg(33%)].  
     The above analysis was carried out also for the stereoisomer I-b and 
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the related glycolipids (entries 6-8, Figure 2-4). The isomer (entry 8) showed 
an overall conformational property similar to I-a and DPPC, though a 
small difference was observed in the conformer distribution at the sugar 
head moiety. However, it should be recognized here that the helical 
direction (helicity) of gt conformer in I-b is reversed (anti-clockwise) from 
the case of DPPC and GGPL-I (clockwise) as depicted in Figures 3 and 5.  
 
 
 
Figure 2-4. Distributions of gg, gt and tg-conformers in 1-substituted sn-glycerols. In these 
sn-isomers, 1 and2 represent dihedral angles around C-C single bond at the glycerol 
sn-2,3 and 1,2 position, respectively. 
 
 
 41 
2-3 Conclusion 
 
   We have proposed an established synthetic pathway to GGPL-I 
homologue and its stereoisomer, in which our one-pot -glycosylation 
methodology was effectively applied. We envisage that the simple method 
will allow us to prepare a variety of -glycolipid antigens other than 
GGPLs and prove their biological significance [43]. By the 1H NMR 
conformational analysis, which was based on our former studies on 
deuterium-labeled sn-glycerols and sugars, we have proven that GGPL-I 
and other 3-O-(-D-glucopyranosyl)-sn-glycerolipids have a common 
conformational property at the chiral glycerol moiety: The lipid tail moiety 
prefers two gauche-conformations (gg and gt) in the order as gt > gg >> tg, 
while the sugar head moiety adopts three conformers in an averaged 
population (gg=gt=tg). At the lipid tail position, the gt-conformer with 
clock-wise helicity is predominated over the anti-clockwise gg-conformer. 
The observed conformation was very close to what we have seen in DPPC 
(Figure 2-5). Although these results were based on the solution state in a 
solvent mixture of CHCl3 and CH3OH (10:1), it may be possible to assume 
that the Mycoplasma GGPLs and the related 
3-O-(-D-glycopyranosyl)-sn-glycerolipids can constitute cytoplasm 
membranes in good cooperation with ubiquitous phospholipids without 
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inducing stereochemical stress at the membrane.  
 
Figure 2-5.  A common conformational property of GGPL-I and DPPC. The tail lipid 
moiety favors two gauche-conformers of gt and gg (gt > gg >> tg), while the head moiety 
takes three conformers in averaged populations (gt = gg = tg). 
 
The GGPL-I isomer (I-b) showed an overall conformational property 
similar to the natural isomer (I-a) and DPPC. However, it should be 
mentioned here that the chiral helicity of gt conformers in I-b is reversed 
(anti-clockwise) from the clockwise helicity of DPPC and GGPL-I. The 
difference in chirality seems critical in biological recognition events and also 
in physicochemical contact with other chiral constituents in cell 
membranes [44,45].  
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2-4   Experimental Section 
 
General Methods 
 
    Infrared (IR) spectra were recorded on a JASCO FT/IR-230 Fourier 
transform infrared spectrometer on the form of KBr disks. All 1H NMR 
(500 MHz) spectra were recorded using Varian INOVA-500 or Varian 
Gemini 200. 1H chemical shifts are expressed in parts per million (ppm) 
by using an internal standard of tetramethylsilane (TMS = 0.000 ppm). 
Mass spectra were recorded with a JEOL JMS 700 spectrometer for fast 
atom bombardment (FAB) spectra. Silica gel column chromatography was 
performed on silica gel 60 (Merck 0.063-0.200 mm and 0.040-0.063 mm) 
and eluted with a mixture of toluene and ethyl acetate or a mixture of 
CHCl3 and CH3OH in gradient modes (100:0 to 80:20). For purification of 
phosphocholine containing products, a column chromatography packed 
with Iatrobeads (IATRON LABORATORIES  INC., 6RS-8060) was 
applied and euluted with a mixture of CH3OH and CHCl3 in gradient 
modes. For thin layer chromatography (TLC) analysis, Merck pre-coated 
TLC plates (silica gel 60 F254, layer thickness 0.25mm) and Merck TLC 
aluminum roles (silica gel 60 F254, layer thickness 0.2mm) were used. All 
other chemicals were purchased from Tokyo Kasei Kogyo Co., Ltd., Kishida 
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Chemical Co., Ltd., and Sigma Aldrich Chemical Company Co, Int., and 
were used without further purification. 
    A typical procedure for the one-pot -glycosylation: CBr4 (1.6 g, 6.09 
mmol) and Ph3P (2.02 g, 6.09 mmol) were added to a solution of 
6-O-acetyl-2,3,4-tri-O-benzyl-D-glucose1 (1.0 g, 2.03 mmol) in 10 mL of 
DMF and stirred for 3 h at room temperature. Then, (S)-glycidol (301 mg, 
4.06 mmol) was added to the reaction mixture and stirred for 14 h at room 
temperature. Products were diluted with a mixture of toluene and ethyl 
acetate (10:1), and the solution washed with saturated aq. NaHCO3 and aq. 
NaCl solution, dried and concentrated. The residue was purified by silica 
gel column chromatography in toluene and ethyl acetate to give a mixture 
of 4a and 5a (the ratio changed with reaction time) as colorless syrup. The 
total yield of 4a and 5a was between 80% and 90%.  
  
3-O-(2,3,4-tri-O-benzyl--D-glucopyranosyl)-1,2-di-O-palmitoyl-sn-glycerols 
(8a and 8b):K2CO3 (379mg, 2.74 mmol) was added to the mixture of 4a and 
5a (1 g, 1.83 mmol based on 4a) in CH3OH (20 mL) and stirred for 1 h at 
room temperature. The reaction mixture was neutralized, washed with 
water, dried, and concentrated. The residue was dried under diminished 
pressure and subjected to the next reaction. A mixture of the crude residue 
6a and cesium palmitate (2.7 g, 7.3 mmol) in DMF (40 mL) was heated at 
 45 
100~110 ˚C, to which the DMF solution of the residue was added slowly. 
The reaction mixture was stirred for 2 h at 110 ˚C, cooled to room 
temperature, and then, filtered with a pad of Celite powder and ethyl 
acetate. The filtrate was washed with saturated aq. NaCl solution, dried, 
and concentrated. The residue was purified by silica gel column 
chromatography to give 6a as a colorless syrup (830 mg, 60% yield). To a 
solution of 6a (300 mg, 0.39 mmol) in pyridine (20 mL) was added TBDMS 
chloride (107 mg, 0.71 mmol) and 4-N,N-dimethylaminopyridine (cat.) 
were added. The reaction mixture was stirred for 12 h at room temperature, 
treated with methanol (2 mL) for 3 h and concentrated. The residue was 
purified by silica gel column chromatography in a mixture of toluene and 
ethyl acetate. The main product was dissolved in pyridine (20 mL) and 
then reacted with palmitoyl chloride (162 mg, 0.59 mmol) for 3 h 
at room temperature. The reaction mixture was mixed with 
methanol (2mL) and then concentrated with toluene. The 
residue was dissolved in a mixture of CH3OH and CH2Cl2 (1:1, 
20 mL) and treated with trifluoroacetic acid (1 mL) for 2 h at 
room temperature. After concentration, the residue was purified 
by silica gel column chromatography in a mixture of tolune and 
ethyl acetate to give 8a as a white waxy solid (0.32 g, 81 % yield 
from 6a).[]D30 = +21.1 (c 1.0, CHCl3); IR (KBr film): 3413, 2923, 2853, 
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1736, 1630, 1457, 1361, 1158, 1069, 736 cm-1; 1H-NMR (500 MHz, 
CDCl3): H 7.40~7.23 (m, 5Hx3, -CH2C6H5), 5.23 (m, 1H, glycerol H-2), 
4.96~4.64 (d, 2Hx3,-CH2C6H5), 4.70 (d, 1H, J=3.5Hz, H-1), 4.40 (dd, 1H, 
J=4.0 and 12.0Hz, glycerol H-1proS), 4.19 (dd, 1H, J=6.0 and 12.0Hz, glycerol 
H-1proR), 3.96 (dd, 1H, J=9.5 and 9.5Hz, H-3), 3.72 (dd, 1H, J=5.5 and 
10.5Hz, glycerol H-3proR), 3.72 and 3.66 (b, 2H, H-6ProR and H-6proS), 3.65 (m, 
1H, H-5), 3.54 (dd, 1H, J=5.5 and 10.5Hz, glycerol H-3proS), 3.50 (dd, 1H, 
J=9.5 and 10.0Hz, H-4), 3.49 (dd, 1H, J=3.5 and 9.5Hz, H-2), 2.29 (m, 2Hx2,  
-OCOCH2CH2(CH2)12CH3), 1.58 (b, 2Hx2, -OCOCH2CH2(CH2)12CH3), 1.25 
(b, 24Hx2,-OCOCH2CH2(CH2)12CH3), 0.88 (t, 3Hx2, J=7.0Hz, 
-OCOCH2CH2(CH2)12CH3); MS (FAB):cald for C62H96O10Na([M+Na]+) 
1023.69; found 1023.7. 
    In the same way as derived for the synthesis of 8a, (R)-glycidol and 6b 
(0.30 g, 0.39 mmol) was used for the synthesis of 8b (0.30 g, 77 % yield) 
[]D32= +18.5 (c 1.0, CHCl3); IR (KBr film): 3452, 2924, 2854, 1739, 1586, 
1455, 1296, 1159, 1095, 710 cm-1; 1H-NMR (500 MHz, CDCl3 H 
7.40~7.23 (m, 5Hx3, -CH2C6H5), 5.23 (b, 1H, glycerol H-2), 4.96~4.63 (d, 
2Hx3,-CH2C6H5), 4.75 (d, 1H, J=3.5Hz, H-1), 4.38 (dd, 1H, J=3.5 and 
12.0Hz, glycerol H-3proR), 4.21 (dd, 1H, J=6.5 and 12.0Hz, glycerol H-3proS), 
3.96 (dd, 1H, J=9.5 and 9.5Hz, H-3), 3.73 (dd, 1H, J=6.0 and 11.0Hz, 
glycerol H-1proS), 3.76 and 3.66 (b, 2H, H-6ProR and H-6proS), 3.65 (m, 1H, H-5), 
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3.57 (dd, 1H, J=5.5 and 11.0Hz, glycerol H-1proR), 3.51 (dd, 1H, J=9.5 and 
10.0Hz, H-4), 3.50 (dd, 1H, J=3.5 and 9.5Hz, H-2), 2.29 (b, 2Hx2,  
-OCOCH2CH2(CH2)12CH3), 1.59 (b, 2Hx2, -OCOCH2CH2(CH2)12CH3), 1.25 
(b, 24Hx2, -OCOCH2CH2(CH2)12CH3), 0.88 (t, 3Hx2, J=7.0Hz, 
-OCOCH2CH2(CH2)12CH3); MS (FAB): m/z calcd for C62H96O10Na([M+Na]+) 
1023.69; found 1023.7. 
 
A phosphorodiamidite method for the synthesis of I-a:  
 
a) Reaction vessel was kept anhydrous condition with Ar gas in the 
presence of molecular sieves (50%w/w), and a solution of 8a (0.20 g, 0.20 
mmol) and 2-cyanoethyl-N,N,N',N'-tetraisopropyl  phosphorodiamidite 
(90.4 mg, 0.30mmol) in 10 mL of CH2Cl2 was injected. 1H-tetrazole (28.4 
mg, 0.40 mmol) was added and stirred for 2 h at room temperature. Then 
1H-tetrazole (42.6 mg, 0.60 mmol, 3.0equiv) and choline tosylate (220.3 mg, 
0.8 mmol: thoroughly dried overnight under vacuum) were added to a 
reaction mixture and stirred for 1.5 h at room temperature. Reaction was 
quenched by the addition of water (1 mL), then m-chloroperbenzoic acid 
(51.8 mg, 0.3 mmol) was added at 0˚C and stirred for 10 min at room 
temperature. Reaction mixture was washed with 10 % aq. Na2SO3 solution, 
saturated aq. NaHCO3 solution, water and saturated aq. NaCl solution, 
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dried and concentrated. The residue was dissolved in a mixture of CH3OH 
(10 mL) and of 30% aq. NH3 (1 mL) and stirred for 15 min at room 
temperature. The reaction mixture was concentrated, and the residue was 
purified by column chromatography (IATROBEADS in a mixture of CHCl3 
and CH3OH) to give 9a (186 mg, 80% yield). []D26 +13.0 (c 0.45, CHCl3); IR 
(KBr film): 3301, 2929, 2856, 2537, 1731, 1577, 1419, 1216, 1093, 925, 788, 
746; 1H-NMR (500 MHz, CDCl3): H 7.35~7.25 (m, 5Hx3, - CH2C6H5), 5.22 
(m, 1H, glycerol H-2), 4.93~4.61 (d, 2Hx3, - CH2C6H5), 4.70 (d, 1H, J=3.5Hz, 
H-1), 4.38 (dd, 1H, J=3.0 and 12.0Hz, glycerol H-1proS), 4.19 (b, 2H, choline 
–CH2CH2N+(CH3)3), 4.17 (dd, 1H, J=6.5 and 12.0Hz, glycerol H-1proR), 4.15 
and 4.02 (mx2, 2H, H-6ProR and H-6proS), 3.93 (dd, 1H, J=9.0 and 9.5Hz, H-3), 
3.72 (dd, 1H, J=5.5 and 11.0Hz, glycerol H-3proR), 3.71 (b, 1H, H-5), 3.62 (t, 
1H, H-4), 3.58 (b, 2H, choline –CH2CH2N+(CH3)3), 3.52 (dd, 1H, J=6.0 and 
11.0Hz, glycerol H-3proS), 3.46 (dd, 1H, J=3.5 and 9.5Hz, H-2), 3.15 (s, 9H,  
-POCH2CH2N+(CH3)3), 2.28 (m, 2Hx2, -OCOCH2CH2(CH2)12CH3), 1.58 (b, 
2Hx2, -OCOCH2CH2(CH2)12CH3), 1.25 (b, 24Hx2, 
-OCOCH2CH2(CH2)12CH3), 0.88  (t, 3Hx2, J=7.0Hz, 
-OCOCH2CH2(CH2)12CH3); MS (FAB): m/z calcd for 
C67H108NO13PNa([M+Na]+) 1188.75; found 1188.7.  
 
b) Compound 9a (0.18 g, 0.15 mmol) was hydrogenated with Pd(OH)2/C 
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(8mg) under atmospheric pressure in a mixture of CH3OH (10 ml) and 
acetic acid (0.1 mL) for 7 h (room temperature). The reaction mixture was 
neutralized by addition of Et3N, filtered and concentrated. The residue was 
purified by column chromatography with IATROBEADS (CH3OH and 
CHCl3) to give I-a (101 mg, 75 % yield). []D31= +18.7 (c 1.0, 
CHCl3:CH3OH=10:1); IR (KBr film): 3372, 2927, 2852, 1731, 1573, 1469, 
1112, 975, 727; 1H-NMR (500 MHz, CDCl3:CD3OD=10:1): H 5.23 (m, 1H, 
glycerol H-2), 4.80 (d, 1H, J=3.5Hz, H-1), 4.39 (dd, 1H, J=3.5 and 12.0Hz, 
glycerol H-1proS), 4.30 (b, 2H, –CH2CH2N+(CH3)3), 4.24 and 3.95 (b, 2H, 
H-6ProR and H-6proS), 4.14 (dd, 1H, J=6.5 and 12.0Hz, glycerol H-1proR), 3.75 
(dd, 1H, J=5.5 and 11.0Hz, glycerol H-3proR), 3.67 (b, 2H, choline 
–CH2CH2N+(CH3)3), ~3.65 (b, 1Hx2, H-3 and H-5), 3.61 (dd, 1H, J=5.5 and 
11.0Hz, glycerol H-3proS), 3.56 (b, 1H, H-4) 3.46 (b, 1H, H-2), 3.22 (s, 9H, 
-POCH2CH2N+(CH3)3), 2.31 (m, 2Hx2, -OCOCH2CH2(CH2)12CH3), 1.60 (b, 
2Hx2, -OCOCH2CH2(CH2)12CH3), 1.25 (b, 24Hx2, 
-OCOCH2CH2(CH2)12CH3), 0.88  (t, 3Hx2, J=7.0Hz, 
-OCOCH2CH2(CH2)12CH3); HRMS (FAB): m/z calcd for C46H90NO13PNa 
([M+Na]+);918.6048, found; 918.6028. 
    In the same way as described above, 9b (180 mg) was derived from 
8b (200 mg, 0.20 mmol) in 76 % yield and converted to the 
GGPL-I isomer I-b [70 mg, 81 % yield from 9b (120 mg)]. 9b: 
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[]D26= +8.1 (c 0.62, CHCl3); IR (KBr film): 3413, 2923, 2857, 1735, 1461, 
1241, 1097, 744, 495, 445; 1H-NMR (500 MHz, CDCl3): H 7.35~7.23 (m, 
5Hx3, -CH2C6H5), 5.23 (b, 1H, glycerol H-2), 4.94~4.64 (d, 2Hx3,-CH2C6H5), 
4.74 (d, 1H, J=3.5Hz, H-1), 4.37 (dd, 1H, J=3.0 and 12.0Hz, glycerol H-3proR), 
4.23 (b, 2H, choline –CH2CH2N+(CH3)3), 4.19 (dd, 1H, J=6.5 and 12.0Hz, 
glycerol H-3proS), 4.16 and 4.09 (b, 2H, H-6proR and H-6proS), 3.94 (dd, 1H, 
J=9.5 and 9.5Hz, H-3), 3.76 (dd, 1H, J=5.5 and 11.0Hz, glycerol H-1proS), 
3.72 (m, 1H, H-5), 3.61 (dd, 1H, J=9.0 and 9.5Hz, H-4), 3.60 (b, 2H, choline 
–CH2CH2N+(CH3)3), 3.57 (dd, 1H, J=5.5 and 11.0Hz, glycerol H-1proR), 3.49 
(dd, 1H, J=3.5 and 9.5Hz, H-2), 3.20 (s, 9H, choline –CH2CH2N+(CH3)3), 
2.28 (dd, 2Hx2, J=7.5 and 15Hz, -OCOCH2CH2(CH2)12CH3), 1.58 (b, 2Hx2, 
-OCOCH2CH2(CH2)12CH3), 1.25 (b, 24Hx2, -OCOCH2CH2(CH2)12CH3), 0.88 
(t, 3Hx2, J=7.0Hz, -OCOCH2CH2(CH2)12CH3); MS (FAB): m/z calcd for 
C67H108NO13PNa ([M+Na]+) 1188.75; found 1188.7.  
 
I-b: []D31= +10.7 (c 1.0, CHCl3:CH3OH=10:1); IR (KBr film): 3390, 2919, 
2856, 1731, 1463, 1228, 1074, 964, 711; 1H-NMR (500 MHz, 
CDCl3:CD3OD=10:1): H 5.24 (m, 1H, glycerol H-2), 4.80 (d, 1H, J=3.5Hz, 
H-1), 4.34 (dd, 1H, J=3.5 and 12.0Hz, glycerol H-3proR), 4.28 (b, 2H, choline 
–CH2CH2N+(CH3)3), 4.25 and 3.97 (b, 2H, H-6ProR and H-6proS), 4.20 (dd, 1H, 
J=7.0 and 12.0Hz, glycerol H-3proS), 3.80 (dd, 1H, J=6.0 and 11.0Hz, glycerol 
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H-1proS), ~3.63 (b, 1Hx2, H-3 and H-5), 3.63 (b, 2H, choline 
–CH2CH2N+(CH3)3), 3.58 (dd, 1H, J=5.5 and 11.0Hz, glycerol H-1proR), 3.55 
(b, 1H, H-4) 3.46 (dd, 1H, H-2), 3.22 (s, 9H, choline –CH2CH2N+(CH3)3), 2.31 
(dd, 2Hx2, J=7.5 and 15Hz, -OCOCH2CH2(CH2)12CH3), 1.60 (b, 2Hx2, 
-OCOCH2CH2(CH2)12CH3), 1.26 (b, 24Hx2, -OCOCH2CH2(CH2)12CH3), 0.88 
(t, 3Hx2, J=7.0Hz, -OCOCH2CH2(CH2)12CH3); HRMS (FAB): m/z calcd for 
C46H90NO13PNa ([M+Na]+) 918.6048; found 918.6078. 
 
3-O-(-D-glucopyranosyl)-1,2-di-O-palmitoyl-sn-glycerol (10 in 
Entry 3): Compound 10 was obtained as a waxy solid (73 mg, 
83% yield) from 8a (120mg,0.12mmol) by catalytic 
hydrogenation under the same reaction conditions as those 
described above in the preparation of I-a. []D30= +27.2 (c 1.0, 
CHCl3:CH3OH=10:1); IR (KBr film): 3411, 2919, 2851, 1739, 1587, 
1465, 1158, 1053, 720 cm-1; 1H-NMR (500 MHz, 
CDCl3:CD3OD=10:1):H 5.25 (m, 1H, glycerol H-2), 4.83 (d, 1H, 
J=3.5Hz, H-1), 4.40 (dd, 1H, J=3.5 and 12.0Hz, glycerol H-1proS), 
4.16 (dd, 1H, J=6.5 and 12.0Hz, glycerol H-1proR), 3.82 (dd, 1H, 
J=5.5 and 10.5Hz, glycerol H-3proR), 3.78 (d, 2H, J=3.5Hz, H-6proR 
and H-6proS), 3.65 (t, 1H, H=9.5 and 9.5Hz, H-3), 3.62 (dd, 1H, 
J=6.0 and 10.5Hz, glycerol H-3proS), 3,56 (dt, 1H, H-5), 3.44 (dd, 
 52 
1H, J=3.5 and 9.5Hz, H-2), 3.42 (dd, 1H, J=8.5 and 10.0, H-4),  
2.32 (dt, 2Hx2, -OCOCH2CH2(CH2)12CH3), 1.61 (b, 2Hx2, 
-OCOCH2CH2(CH2)12CH3), 1.26 (b, 24Hx2, -OCOCH2CH2(CH2)12 
CH3), 0.88 (t, 3Hx2, J=7.0Hz, -OCOCH2CH2(CH2)12CH3); HRMS 
(FAB): m/z calcd for C41H78O10Na ([M+Na]+) 753.5493;found 753.5519. 
 
3-O-(6-O-palmitoyl--D-glucopyranosyl)-1,2-di-O-palmitoyl-sn-g
lycerol (11 in Entry 4): A mixture of 8a (120 mg, 0.12 mmol) and 
palmitoyl chloride (165 mg, 0.6 mmol) in pyridine was stirred at 
room temperature for 3 h and then treated with CH3OH (1 mL) 
for 3 h. After concentration in vacuo, the residue was purified on 
silica gel (toluene + ethyl acetate). The main product (138 mg) 
was dissolved in a mixture of cyclohexene and ethanol (1:4) and 
subjected to catalytic hydrogenation at atmospheric pressure in 
the presence of Pd(OH)2/C (50 mg). The product was purified by 
silica gel column chromatography (CH3OH+CHCl3) to afford 11 
(99 mg, 85% yield from 8a). []D30= +20.9 (c 1.0, CHCl3:CH3OH=10:1); 
IR (KBr film): 3414, 2919, 2851, 1739, 1605, 1465, 1375, 1176, 
1054, 720 cm-1; 1H-NMR (500 MHz, CDCl3:CD3 H 
5.25 (m, 1H, glycerol H-2), 4.82 (d, 1H, J=4.0Hz, H-1), 4.40 (dd, 
1H, J=3.5 and 12.0Hz, glycerol H-1proS), 4.34 and 4.30 (ddx2, 2H, 
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J=5.0 and 12.0, 2.5 and 12.0Hz, H-6proR and H-6proS), 4.16 (dd, 
1H, J=6.5 and 12.0Hz, glycerol H-1proR), 3.82 (dd, 1H, J=5.0 and 
10.5Hz, glycerol H-3proR), 3.73 (m, 1H, H-5), 3.65 (dd, 1H, H=9.0 
and 9.5Hz, H-3), 3.61 (dd, 1H, J=5.5 and 10.5Hz, glycerol 
H-3proS), 3.45 (dd, 1H, J=4.0 and 9.5Hz, H-2), 3.33 (dd, 1H, J=9.0 
and 10.0, H-4), ~2.33 (m, 2Hx3, -OCOCH2CH2(CH2)12CH3),  
1.61 (b, 2Hx3, -OCOCH2CH2(CH2)12CH3), 1.26 (b, 24Hx3, 
-OCOCH2CH2(CH2)12CH3), 0.88 (t, 3Hx3, J=7.0Hz, -OCOCH2 
CH2(CH2)12CH3); HRMS (FAB): m/z calcd for C57H108O11Na ([M+Na]+) 
991.7789; found 991.7832. 
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Chapter 3 
Comparative analyses of helical property in asymmetric 
1,2-di-O-acyl-sn-glycerols  
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3-1 Introduction 
 
 Glycerol is a naturally occurring symmetric compound, and 
the prochiral positions are defined as sn-glycerol according to 
the IUPAC rule of stereospecific numbering.1 An important part 
of stereochemistry in the sn-glycerol arises from the fact that it 
is a “prochiral compound.” This means that when either the sn-1 
or sn-3 position is modified in either a chemical or a biological 
pathway,2 the glycerol derivative becomes optically active. 
Actually, both naturally occurring phospholipids and glycolipids 
in cytoplasm membranes are chiral and optically active. They 
possess polar substituent groups usually at sn-3 position to have 
the common asymmetric skeleton of 1,2-di-O-acyl-sn-glycerol. 
Another important stereochemical factor arises from that fact 
that they are the acyclic compounds allowing free rotation at 
each C-C single bond. Assumed that there are three staggering 
conformers at each of the sn-1 and sn-3 positions, the 
asymmetric sn-glycerol skeleton can give nine different 
conformers.3  
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Figure 3-1 
  In our preceding studies,4,5 we reported the synthesis and 
1H NMR characterization of chirally 2H-labelled sn-glycerols 1a 
and 1b (Figure 3-1) and their esters (acetate, benzoate and 
palmitate). These 2H-labelled compounds served as probes 
useful for discriminating each of diastereomeric protons in the 
prochiral sn-glycerol skeleton with 1H NMR spectroscopy and 
have enabled us to examine conformational behaviors in both 
symmetric and asymmetric sn-glycerols5,6 including 
Mycoplasma -glycolipids.7  
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Figure 3-2 
 Extensive studies have been directed to the analysis of 
thermodynamic behaviors of cell-membrane phospholipids.8-12 
Along these studies, it has become widely accepted that 
phospholipids adopt two gauche conformers (gg and tg) at the 
tail in such a way of allowing stacking interaction (Figure 3-2). 
Hauser et al. 13 reported 1H and 31P NMR analyses for a series of 
phospholipids in both solution and semi-solution states that the 
lipid tail favored the two gauche conformers irrespectively of the 
solvents used and the functional groups attached to the head 
group. In our preceding study, we observed an analogous 
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behavior in conformational properties also in Mycoplasma 
fermentans -glycolipids (GGPLs).7 Here, we can see in Figure 
3-2 that the gauche-conformers [gt-(+) and gg-(-)] have helicity 
with sign reversed each other. It is obvious that the helicity 
around sn-1,2 di-O-acyl groups can become one of important 
stereochemical factors for characterizing 
1,2-di-O-acyl-sn-glycerols as asymmetric biomaterials 
responsible for formation of cytoplasm membranes.  
 
Figure 3-3 
 A few decades ago, we reported chiroptical properties of 
various 1,2-di-O-benzoyl-sn-glycerols (Figure 3-3) and the 
related chiral sn-glycerols by means of optical rotatory 
dispersion (ORD) and circular dichroism (CD).6,14 During these 
studies, we recognized that intensity of their CD bands varied 
extensively among compounds 2~8.6 It was possible that helical 
property around the sn-1,2 di-O-acyl groups could be influenced 
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largely by sn-3 substituting groups besides the absolute 
sn-configuration. Since these chiral sn-glycerols are thought to 
serve as good models for studies on phospholipids and 
glycolipids, we examined conformational properties of in 2~8 in 
methanol solutions by means of CD and 1H NMR spectroscopy 
as independent approaches. In this paper, we reported the 
results in terms of comparative analyses of helical property and 
notable effects of sn-3 substituting groups in the asymmetric 
1,2-di-O-acyl-sn-glycerols in a solution state.  
 
3-2 Materials and Methods 
 
   Model compounds: All compounds studied here including 
tri-O-benzoyl derivatives of 1a and 1b5 and model compounds 
2~86 were prepared in our former studies, and both of their 
absolute configuration and optical purity were already 
established. For compound 3 with 3-O--L-Glc linkage, an 
optical isomer 3a with -D-Glc linkage at sn-1 
[2,3-di-O-benzoyl-1-O-(2,3,4-tetra-O-acetyl--D-glucopyranosyl)-
sn-glycerol] was prepared14 and is being handled in the present 
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study as -L-Glc isomer 3. This was made to simplify discussion.  
1H NMR and CD analyses: All compounds 2~8 were dissolved in 
either methanol (10 M) or methanol-d4 (ca. 10 mM) for 1H NMR 
(400 and 500 MHz) and CD analysis respectively.  1H NMR 
data [chemical shift ( ppm), coupling constants (Hz) in Table 
1-3] as well as the CD and UV data [molecular ellipticity 
([]max) of band 1 and band 2 and  values (max) in Table 1-1) 
were assembled from our original data6 and analyzed with 
Karplus equations to obtain information on helicity indexes 
(sign, intensity, disparity and volume). Three Karplus equations 
(eq. B-1, eq. B-2 and eq. B-3, equation 2) were derived from a 
general equation (equation 1) of Haasnoot15 and used for 
calculation of three helical conformers with a PC soft (free in 
e-mail contact with Yuan Mengfei, Chiba University). For this 
analysis, 1H NMR coupling constants were collected from 
expanded spectra in first order analysis and checked with 
second order analysis in case of AMX spin system. 
Discrimination of diastereomeric protons (H1proR and H1proS) 
was conducted on the basis of NMR data of tri-O-benzoates 
derivatives 1a and 1b as we described previously.6  
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3-3 Results and Discussion 
1.  Analysis of helical property by means of circular dichroism 
(CD) spectroscopy 
As shown in Figure 3-4, the CD spectra of both 2 and 3 gave 
typical exciton coupling CD bands with a positive peak at ca. 
235 nm (band 1) and a negative one at ca. 220 nm (band 2). All 
these model compounds 4~8 gave couplet CD bands with 
(+)-sign as summarized in Table 3-1, and this result allowed us 
to conclude in a preceding paper6 that “CD di-benzoate chirality 
rule” by Nakanishi and Harada16,17 provides us with a general 
tool useful for assignment of glycerol sn-configurations. At the 
same time, it had become obvious that these 
1,2-di-O-benzoyl-sn-glycerols adopt the gt-(+) conformer with 
right-handed helicity more than the antipodal gg-(-) one in 
conformation equilibrium among three staggered conformers 
and hold a persistent order of gg-(+) > gg-(-) > tg (Figure 3-2). 
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Figure 3-4 CD spetra of 2 and 3 in MeOH 
 
On the other hand, it was notable that intensity of the 
exciton coupling bands varied widely between the two 
-glycosylated derivatives (2 and 3) and also among the 
compounds studied here. This result has disclosed that position 
of the conformation equilibrium can vary more extensively than 
what we could expect for the two glycosyl isomers. This 
consideration prompted us to reinvestigate conformation 
behaviors of 2~8 in terms of helical property and elucidate 
possible effects of the sn-3 substituting group.  
 To correlate between CD and 1H NMR data, we introduced 
“helicity index” as given in Table 3-1 and Table 3-2. The helicity 
index (CD) covers information on the sign and intensity of 
helicity at sn-1,2 di-O-benzoate which can be determined by the  
exciton coupling CD bands on the basis of the “di-benzoate 
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chirality method” of Nakanishi and Harada.16 There, the 
intensity (CD) was defined as sum of peak intensity ( or 
[]max) of the two couplet CD bands (band 1 and band 2) which 
is considered proportional to the intensity of di-benzoate exciton 
coupling interactions. 
 
Table 3-1 CD and UV data of compounds 2~8 in methanol solution and 
“helicity index (CD)” derived from di-benzoate exciton coupling CD bands 
(band 1 and band 2) 
 
UV data
(CH3OH)
No X  =
2 -D-Glc(Ac4)-O- +21.6 (234) - 5.6 (220) 2.0 (229) + 27
3 -L-Glc(Ac4)-O- +7.6 (237) -4.8 (222) 2.3 (229) + 12
4 H- +25.2 (235) -6.9 (222) 2.1 (229) + 32
5 N=N=N- +10.2 (236) -9.0 (222) 1.9 (230) + 19
6 CH3(CH2)5CH2-O- +13.6 (236) -8.4 (220) 1.8 (230) + 22
7 CH3COO- +3.0 (239) -4.9 (226) 2.0 (230) + 8
8 CH3(CH2)14COO- +1.4 (236) -2.5 (226) 2.1 (230) + 4
Compounds 
CD data (CH3OH)
[]max  x 10-3  (max  nm)
band 1
(first band)
band 2
(second band)
sign
intensity (CD)
[band 1+band 2]
Helic ity Index (CD)
  x10-1
(max nm)
 
 
The helical index (CD) gives us precise information on 
conformation equilibrium among the three helical conformers as 
depicted in Figure 3-2. For example, the (+)-sign was indicative 
of predominance of the gt-(+) conformer with right-handed 
helicity in this equilibrium in an order as gt-(+) > gg-(-) in the 
equilibrium. This relation was maintained in all compounds 
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studied here irrespective of the sn-substituting groups. The 
intensity (CD) is considered to vary among them depending on 
degree of disparity between the two gauche-conformers [gt-(+) 
and gg-(-)] with revered helicity sign. The sn-3 substituting 
groups can contribute to this disparity while keeping the 
persistent order of gt-(+) > gg-(-). Apparently, it is integrated in 
the compound 2 with -D-Glc linkage rather than in 3 with 
-L-Glc isomer since the intensity (CD) of 2 was more than two 
times higher than that of 3. The sn-3 acyl groups in 7 and 8 are 
thought to a notable effect which averages the disparity between 
the two gauche-conformers.  
 
2. Analysis of helical property by means of 1H NMR spectroscopy 
 
 For the purpose of analyzing the conformational equilibrium, 
we have conveniently applied a general Karplus equation 
(Equation 1). The following equation was originally proposed by 
Haasnoot el. al.15 who extensively examined roles of electron 
substituting groups on vicinal 1H-1H coupling constants (3J Hz). 
This equation is useful for analysis of those compounds having a 
tri-substituted C-C single bond like sn-glycerols the 
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tri-substituted system at sn-1,2 position and hexoses at C5-C6 
position.18 
 
 
Equation 1 
 Here, above equation was extended to the following three 
equations (eq. B-1, eq. B-2 and eq. B-3 (Equation 2), each of 
which enables us to calculate time-averaged populations (%) of 
the three conformers. In the present 1H NMR analysis, a set of 
vicinal coupling constants of H-1proR and H-1proS is applied. 
The two diastereomeric protons were discriminated with 
benzoyl derivatives of the chirally deuterium-labelled 
compounds 1a and 1b (Figure 3-1). Equation B-1 is a basic 
equation which has been commonly used in our analyses of 
sn-glycerols.3-7  
 In eq. B-2 and eq. B-3, possible deviations from perfect 
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staggering are taken into accounts in each of the rotamers. This 
is because there was a clear tendency in X-ray data that 
dihedral angles (1) of vicinal oxygens tended to allow 
deviations from perfect staggered angle (1 = + 60°) by ca. + 
5°.18,19  
 
3J H1proS,H2 = 2.8 3.1 10.7
3J H1proR,H2 = 0.9 10.7 5.0
3J H1proS,H2 = 2.3 2.5 10.7
3J H1proR,H2 = 1.3 10.2 5.0
3J H1proS,H2 = 2.3 2.5 10.6
3J H1proR,H2 = 1.3 10.2 5.8
3J values (Hz) gt-(+) gg-(-) tg
eq.  B-1
(+60, -60, 180)
eq.  B-2
(+65, -65, 180)
eq. B-3
(+65, -65, 185)
Equations
(F1 in each rotamer)
 
Equation 2 
 
Table 3-2  1H NMR data of 1,2-di-O-benzoyl-sn-glycerols (2~8) in 
CD3OD solution and “helicity index (1H NMR)” available from vicinal 
coupling constants (Hz)  
 
No X  =  H1proR H1proS
2 -D-Glc(Ac4)-O- 4.60 (6.6) 4.70 (3.6) 55 37 8 + 18 92
3 -L-Glc(Ac4)-O- 4.53 (6.2) 4.70 (3.9) 50 39 11 + 11 89
4 H- 4.49 (7.0) 4.60 (3.3) 60 35 5 + 25 95
5 N=N=N- 4.57 (6.5) 4.71 (4.2) 51 34 15 + 17 85
6 CH3(CH2)5CH2-O- 4.59 (6.6) 4.70 (3.7) 54 37 9 + 17 91
7 CH3COO- 4.60 (6.1) 4.70 (4.2) 47 38 15 + 9 85
8 CH3(CH2)14COO- 4.60 (5.8) 4.70 (4.2) 44 41 15 + 3 85
gg
(-60)
tg
(180)
disparity
[gt-gg] %
Rotamer populations  (%)
(1 degree)
volume
[gt+gg] %
Helicity Index (
1
H NMR)
at sn-1,2 position
sign
 ppm (3J H1,H2 Hz)
1
H NMR data
(CD3OD)Compounds 
gt
（+60）
 
 
 Results of our 1H NMR using the standard equation (eq. B-1) 
were summarized together with the helicity index (1H NMR) in 
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Table 3-2. The population is given as time-averaged populations 
(%) of each rotamer which can interconvert each other much 
faster (order of 10-6~10-9 second) than 1H NMR time scale (order 
of 10-3 seconds) in solution states. “Helicity index (1H NMR)” is 
composed of three stereochemical items (sign, intensity-2 and 
volume) useful for charactering helical property around the 
sn-1,2 position. The sign and intensity-2 are defined as 
difference in populations between gt-(+) and gg-(-) conformers: 
the sign becomes positive (+), and the intensity-2 becomes 
stronger as the right-handed helical conformer increases 
relative to the left-handed one. Obviously, these indexes should 
correspond to the helicity index (CD) which was discussed in 
preceding section. In the helicity index (1H NMR), “volume” was 
added as a new index to characterize the helical property.  The 
“volume” is defined as the sum of gt-(+) and gg-(-) population (%) 
which indicates the total volume of these two gauche-conformers 
in equilibrium. 
  1H NMR data of compounds 2~8 gave a persistent relation of 
3JH1proR,H2 > JH1proS,H2 (Hz) and H1proS > H1proR 
(ppm), though there were some deviations in both chemical 
shifts and coupling constants among these compounds. The 
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conformer populations calculated with eq. B-1 have shown that 
all compounds studied here favor gt-(+) conformer with 
right-handed helicity more than gg-(-) with left-handed helicity. 
Thus, the (+)-sign in the helicity index completely matched with 
the (+)-sign in CD indexes. Disparity (%) between the two 
helical conformers varied among the compounds similarly to the 
values in the CD intensity. The helical volume (%) was greater 
than 80% indicating that the two helical conformers (gt and gg) 
were predominant over tg-conformer.  
 
 
Figure 3-5 Correlation between helical intensity (CD) and 1H NMR 
data:  
(a) helical intensity and (b) helical volume (%)   
 
  Here, it may be of interest to mention that compound 4, 
which is the smallest chiral 1,2-diol derivative, can show the 
highest intensity in both 1H NMR and CD indexes, while 
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compound 8 with a long fatty acid (C16) ester has shown the 
weakest helical property around the di-O-benzoates, Here, we 
plotted each value in intensity (CD) against those in the helical 
disparity (1H NMR) for correlation between the two independent 
approaches. As shown in Figure 3-5a, it was found that the 
helical intensity (CD) holds a linear relation with the NMR 
index. It is obvious that the two independent approaches are in 
good agreement in analyses of helical property in the 
asymmetric 1,2-di-O-benzoyl-sn-glycerols.  
 Next, intensity (CD) values were plotted against the NMR 
helical volume. As shown in Figure 3-5b, values in the helical 
intensity (CD) is nearly proportional also to the NMR helical 
volume defined by sum of gt-(+) and gg-(-) conformers (%). This 
means that the degree of helical disparity between the two 
gauche-conformers is associated mainly with change in 
population of gt-(+) rather than that in gg-(-). Here, it was 
notable that compound 5 with azide group showed an 
exceptional behavior. Compounds 5 (-N=N=N) showed a 
behavior analogously to O-acyl derivatives 7 and 8 in the point 
that they have the lowest helical volume (85%). The helical 
property of 5 was, however, different obviously from those of 8 
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(O-palmitate) which showed the lowest value in both helical 
intensity and volume among the model compounds studied here.   
 
Table 3-3 ． 1H NMR analysis of helical properties of 
1,2-di-O-benzoyl-sn-glycerols 2~8 in methanol  
 
2 54 32 14 + 22 86 52 33 15 + 19 85
3 48 34 18 + 14 82 46 36 18 + 10 82
4 60 30 10 + 30 90 59 31 10 + 28 90
5 50 29 21 + 21 79 47 31 22 + 16 78
6 53 32 15 + 21 85 52 33 15 + 19 85
7 45 33 22 + 12 78 43 35 22 + 8 78
8 42 37 21 + 5 79 40 38 22 + 2 78
Helicity Index (NMR)
(eq. B-3)
Rotamers %
(1 degree)
volume
[gt+gg]%
sign
disparity
[gt-gg]%
gt
(+65)
gg
(-65)
tg
(185)
Comp
Helicity Index (NMR)
(eq. B-2)
volume
[gt+gg]%
gt
(+65)
gg
(-65)
tg
(180)
Rotamers %
(1 degree)
sign
disparity
[gt-gg]%
 
 
 When eq. B-2 and eq. B-3 as listed in equation 2 were 
employed instead of eq. B-1, some changes appeared in both 
helical intensity and volume (Table 3-3). But, we have noticed no 
critical change in these NMR data and also in the induced 
helical index by selection of these three equations. In general, 
the use of eq. B-2 and eq. B-3 tends to decrease the helical 
volume (%) and increase the population of anti-periplanar 
tg-conformer. This implies that the standard equation (eq. B-1) 
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may overestimate the helicity volume [gt-(+) and gg-(-)] in 
present analysis as well as “gauche effects” which are often 
argued not only in conformational analyses of sn-glycerols7,8 but 
also in carbohydrates.20-23 In fact, we had concluded previously 
that Mycoplasma -glycosyl-sn-glycerols adopted such an 
ordered conformation as to adopt the two gauche-conformers 
near exclusively at the lipid tail.7 It is also possible that eq. B-2 
may overestimate disparity the helical intensity in comparison 
with eq. B-3, while showing no significant difference in the 
helicity volume (%).  
  In the correlation processes between CD (Table 3-1) and 
NMR data (Table 3- 3), it has been found that the data by eq. 
B-3 can hold a higher linearity (y = 0.82x – 0.03, R2 = 0.958) with 
the CD intensity those by eq. B-1 (y = 0.68x + 2.17, R2 = 0.945) and 
eq. B-2 (y = 0.77x + 4.13, R2 = 0.942). Moreover, the correlation line 
by eq. B-3 passed through the origin (Figure 3-6). On the other 
hand, the data by eq. B-2 showed larger deviation than those by 
eq. B-1. Other than these results, we have collected several 
reasons why eq. B-3 can be recommended in the stereochemical 
study of sn-glycerols including phospholipids and glycolipids 
(Mengfei and Nishida, unpublished).  
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3-4 Conclusion 
 
 We have described about variable helical properties in 
compounds 2~8 as models of 1,2-di-O-acyl-sn-glycerols. The 
independent analyses undertaken with circular dichroic (CD) 
and 1H NMR spectroscopies were in good agreements: all these 
1,2-di-O-benzoyl-sn-glycerols possessed right-handed helicity 
around the sn-1,2 di-O-benzoates regardless of their sn-3 
substituting groups. The gt-(+) conformer was predominated in 
constant over gg-(-) and tg conformers. On the other hand, 
disparity between gt-(+) and gg-(-) conformers was variable 
among these compounds due to notable effects of the sn-3 
substituting groups. The effects can be expressed with the 
correlation line passing thought the origin (Figure 3-6), which 
has been induced in the present study owing to the CD 
di-benzoate chirality method of Nakanishi and Harada,16 the 
general Karplus equation by Haasnoot et al.15 and the chirally 
deuterium-labelling methodology of Ohrui and Meguro et al.24,25  
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Figure 3-6 
 
  As can be seen also in Figure 3-4, helical property around 
the sn-1,2 di-O-benzoates varied largely by the nearby sn-3 
groups. The compound 4 (X = H) without oxygen atom at sn-3 
showed the strongest helical intensity meaning that the sn-3 
oxygen atom in sn-glycerols has a notable effect to average 
disparity between gt-(+) and gg-(-) conformers at sn-1,2 position. 
The sn-3 O-acyl groups in 7 and 8 strongly reduced the helical 
disparity, while keeping the rule of gg-(+) > gg (-). Effects of sn-3 
O-glycoside linkages were changeable by stereochemistry in the 
head sugar groups. Effect of sn-3 azide (-N=N=N) group looked 
very similar to those of O-alkyl groups but could be 
differentiated in the correlation between CD intensity and 1H 
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NMR helicity volume as was shown in Figure 3-5b.   
  It should be mentioned at the end of this summary that 
effects of these sn-3 substituting groups are associated closely 
with the homologous solution state in methanol. The obtained 
effects will be changed widely by the solvents used and other 
surrounding conditions. Our recent interests are focused on 
roles of sn-3 O-glycosyl groups at the head in 
1,2-di-O-acyl-sn-glycerols which possess a strong 
self-assembling property analogously phospholipids. Though 
situations will become more complicated than the present case, 
the approach undertaken here will work effectively towards 
solution of stereochemistry in these biomembrane forming 
1,2-di-O-acyl-sn-glycerols.  
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Chapter 4 
Stereochemical profiles of M. pneumoniae glycolipid 
(-DGGLs) and the relating cell-membrane 
phospholipids and glycolipids 
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4-1 Introdution 
 
. sn-Glycerol as prochiral compound  
 
   Glycerol (1,2,3-propan-triol) is a symmetric three-carbon 
compound, and the prochiral positions are defined with sn-1 and 
sn-3 numbering according to the IUPAC rule of stereospecific 
numbering [1]. Sn-glycerol can be understood in the term of a 
“prochiral compound.”[2] This means that when either the sn-1 
or sn-3 position is chemically modified, the symmetric glycerol 
derivative turns to a chiral compound having an asymmetric 
center at the C-2 position. Actually in nature, the two 
sn-positions are discriminated by both synthetic and degrading 
enzymes, and thus, most of naturally occurring glycerol 
derivatives are optically active chiral compounds.  
 
 
 
 
 
   Figure 4-1. Sn-glycerol as “prochiral compound.” 
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b. Chiral 1,2-di-O-acyl-sn-glycerols in nature  
  
 Cell-membrane phospholipids such as DPPC are also chiral 
lipids, possessing an asymmetric center at the sn-glycerol  
 
 
Figure 4-2. Chiral 1,2-di-O-acyl-sn-glycerols in nature  
 
C-2 position. In both eukaryote and prokaryote biosynthetic 
systems, 1,2-di-O-acyl-sn-glycerol provides a basic asymmetric 
backbone in sn-glycerol phospholipids and glycolipids. The 
sn-1,2 positions are replaced with either O-acyl (ester) or 
O-alkyl (ether) groups. This can be explained in the term of 
“biological homochirality”[3] which expresses that only one of two 
enantiomers is utilized in our life system. 
   The biological homo-chirality is being kept in chlorophile 
photosynthetic systems, Both mono--D-galactopyranosyl 
-sn-glycerolipids (MGDG) and di-galactosyl-sn-glycerolipids 
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(DGDG) are major components of photosynthetic cells, namely, 
thylakoid and believed to play major roles in photosynthesis.[4,5] 
Irrespective of natural sources, the -D-galactopyranosyl 
linkage is attached at the glycerol sn-3 position.[4-7] Obviously, 
the enantiomer selectivity in enzymatic trans-glycosylation 
conforms to the rule of the “biological homo-chirality” . 
 
 
 
 
 
 
Figure 4-3. Synthesis of MGDG and DGDG 
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a) Absolute structures of M. pneumoniae cell-membrane 
glycolipids (-DGGLs) 
 
  It has long been suggested that M. pneumonia may possess 
antigenic peptides or other membrane-bound lipids which 
specifically occur in this microbe.[8] Our research group had 
identified a set of glycolipids (-DGGLs, Figure 4-4) in M. 
pneumonia which serve as the specific antigen.[9,10] They were 
isomers having an identical molecular weight (Mw) each other, 
and their absolute structures were elucidated by chemical 
syntheses of each isomer.[10] In -DGGLs, a 
-D-galactopyranosyl linkage is attached at the glycerol sn-3 
position, and they have another -D-glucosyl (Glc-type) or 
-D-galactosyl (Gal-type) linkage at the galactose O-6 (primary) 
position. 
Figure 4-4. 
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   The overall chemical structures of -DGGLs are very close to 
plant DGDG except for the fact that the non-reducing glycoside 
is bound with -(1→6)-linkage, and the sn-glycerol 1,2-di-O-acyl 
groups are replaced with saturated fatty acid esters (C16 and 
C18).  
The genome size of M. pneumonia is 816kb with 688 open 
reading frames (ORFs) [11,12] which corresponds to less than 20% 
( ca. 18%) of E. coli genome size. The ORFs coding -glycosl 
enzymes (MPM483) have been identified to be in a group of 
CAZy GT-family 2, which utilizes either UDP-Gal or UDP-Glc as 
the glycosyl donor for the biosynthesis of sn-glycerol 
-galactolipids.[13]  
 
b) Conformational property of chiral 1,2-di-O- acyl- sn-glycerols 
     
 The C-C single bonds in the 1,2-di-O-acyl-sn-glycerol give rise 
to rotational conformers, gg (gauche-gauche), gt (gauche-trans) 
and tg (trans-gauche). The molecular conformational flexibility 
as well as the molecular asymmetry seems characteristic of both 
phospholipids and glycolipids made of the acyclic sn-glycerol. It 
can be also considered that a fluid membrane property is 
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ascribable to self-assemble of these surface active compounds 
(amphiphiles). On the other hand, the rotational property along 
each of the glycerol sn-1,2 and sn-2,3 single bonds has rarely 
been studied in the past [14,15] and yet not fully understood.  
 
Figure 4-5. Conformational property around the acyclic sn-glycerol 
moiety 
 
   Since these amphiphilic compounds make self-assembled 
structures, a major part of conformational studies have been 
directed to their liquid crystalline (LC) and gel properties. This 
holds true for the conformational studies on phospholipids 
which constitute self-assembled lamellar structures in LC and 
gel phases depending on surrounding temperatures.[16,17,18]  
For studies on the conformational property of organic 
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compounds, 1H-NMR spectroscopy has provided powerful tools 
and methodologies. By coupling this advanced spectroscopic 
technology with synthetic carbohydrate chemistry, our group 
has analyzed conformational properties of mono-, di- and 
oligosaccharides.[19,20] In the analyses of sn-glycerols (Figure 4-6), 
many analyses have been hampered by the presence of four 
diastereomeric protons at sn-1 and sn-3 positions which make 
1H NMR signals highly complicated.  
 
 
Figure 4-6.  The structure of sn-glycerol 1 and 2a .2b 
We have solved this problem by developing the technology of 
stereoselective deuterium labeling to produce 2a and 2b and 
thereby analyzed conformations in solutions [2,21,22]. Large 1H 
NMR data have been collected by our approach and led to 
formulation of some empirical 1H NMR rules very useful for 
discrimination of the diastereomeric protons, HproR and HproS 
in chiral molecules [22].  
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4-2 Aim of this study 
 
In the preceding chapter (see Chapter 2), our conformation 
analysis was performed for the M. fermentans -glycolipid 
antigen (GGPL-I).[22] There, we have seen that GGPL-I and the 
relating -glycolipids are able to construct a self-assembled 
bilayer membrane together with ubiquitous phospholipids 
without stereochemical stress. This conclusion was based on the 
results that the rotational property of the M. fermentans 
glycolipid (GGPL-I) is very close to that of phospholipids having 
an identical sn-configuration with 1,2-di-O-palmitate structure.  
 
 
Figure 4-7. series of 3-substited 1,2-di-O-acyl-sn-glycerols (compounds 
3~10) including the M. pneumoniae -DGGL 
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Scheme 4-1.  Synthesis of compounds 4 and 5 
 
In the present study, the study was extended to the 
conformation analysis for a series of 3-substited 
1,2-di-O-acyl-sn-glycerols (compounds 3~10)(Figure4-7) 
including the M. pneumoniae -DGGL (compound 3). As 
reference compounds, the author analyzed also the 
1,2-di-O-acetyl derivatives of 3 (-Gal) and 10 (-GGGL) which 
were soluble not only in a mixture of organic solvents (CDCl3 
and CD3OD) but also in pure water (D2O).  
 
4-3 Materials and Methods 
 
a. Preparation of 1,2-di-O-acyl-sn-glycerols: Synthesis of compounds 4 
and 5 were carried out in a manner as outlined in Scheme 4-1.  The 
glycolipids (3, 8-10) were prepared in our established way [10,22]. Other 
compounds were purposed from Tokyo Kasei Kogyo Co. Ltd., (TOKYO) 
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and used without purification.  
 
b. 1H NMR measurement: NMR was measured on JEOL-JNM 
-LAs-500  (500 MHZ) at 25~30℃ in several solvent systems, i.e., CDCl3, a 
mixture of CDCl3 and CD3OD (1:1~1:10) and D2O. Concentrations were set 
at ca. 10mM solution in each solvent.  
 
c, Karplus equations for analysis around the sn-1,2- C-C single bond: 
Each of single C-C single bonds in the sn-glycerol moiety can afford three 
staggered conformers of gg (gauche-gauche), gt (gauche-trans) and tg 
(trans-gauche). In solution and also in self-contacting liquid crystalline (LC) 
states, transition between conformers occurs more quickly (within 
1.0x10-12~1.0x10-10 sec) than NMR time scale (order of 1x10-6 sec). This 
means that NMR singles reflect the position of rotational equilibrium 
among the three conformers. The position of the equilibration can be 
estimated with 1H-1H coupling constants of 1H NMR spectroscopy with 
assist of a general Karplus equation of Haasnoot et al. [23]. 
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Equation-(1) 
3JH,H (Hz) = 13.22cos2F -0.99cosF + R 
R = Sum{Xi[0.87-2.46cos2(rF+19.9ABS(Xi))]}（r = +1 or -1）. 
 
3JH,H (Hz)is a vicinal 1H-1H coupling constant (Hz). R is the sum of 
effects of each electron negative substituent in neighbor to the coupling 
protons 
Table 4-1. Parameters for optimization of Karplus equation 
 
electron negativ ity (Xi)
Dihedral
angles
gg gt tg
X1=C3 0.4 0.4 0.08 F  (O2,O3) -60 60 180
X2=O2 1.3 1.3 1.22
X3=O1 1.3 1.3 1.22
Dihedral angles Dihedral angles gg gt tg
F  (H2,H1proS) -60 60 180
F  (H2,H1proR) 60 180 300
RESULTS
JH2,H1proS (Factor of F ) 2.81 2.81 14.21
JH2,H1proR (Factor of F ) 2.81 14.21 2.81
gg gt tg gg gt tg
Contribution of R R1 (C3) -0.02 0.21 -0.62 0.21 -0.62 -0.02
R2 (O2) 1.11 -1.06 -1.46 -1.06 -1.46 1.11
R3 (O1) -1.06 1.11 -1.46 -1.06 -1.46 1.11
R = SUM(R1,R2,R3) 0.03 0.26 -3.53 -1.91 -3.53 2.20
gg gt tg
JH2,H1proS = 2.8 3.1 10.7
JH2,H1proR = 0.9 10.7 5.0
Induced Karplus
relations
Parameters
Ref : 1) Haasnoot, C. A. G.; de Leeuw, F. A.
A. M.; Altona, C., Tetrahedron, (1980), 36,
2783-2790. 2) Y. Nishida et al, J.
Carbohydrate Chem., (1988), 7 (1) 239-250.
3
JH,H= 13.22cos^2F  -0.99cosF  + R  (effects of electron negative substituents)
R = Sum Xi[0.87-2.46cos^2(rF+19.9ABS(Xi))]　（r = +1 or -1)
Basic Karplus
equation
JH2,H1proS JH2,H1proR
Contribution of F
 
 
    A three-simultaneous Equation- (2) was induced from the general 
Karplus equation-(1). This is optimized for the analysis of acyclic 
1,2-di-O-acyl-sn-glycerols, in which every electron negative substituent in 
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each of the three staggering conformers was taken into accounts.  
 
Equation-(2) 
       2.8gg + 3.1gt + 10.7tg = 3JH2,H1S （or  3JH2,H3R） 
       0.9gg + 10.7gt + 5.0tg = 3JH2,H1R （or 3JH2,H3S） 
           gg + gt + tg = 1 
In the equation-(2), a perfect staggering (1 and 2 = +60, -60 or 180 
degree) is assumed for every rotamer. This equation can be modulated by 
changing the dihedral angle from those in perfect staggering when it is 
considered necessary [20] .The optimization process by changing the electron 
negativity and the dihedral angles can be performed with a PC software 
(free software in Microsoft Excel, Nishida & Yuan, Chiba University, 2015, 
Table 4-1).  
 
4-4 Results and Discussion 
 
a) Conformational property of 1,2-di-O-palmitoyl-sn-glycerols with a 
hydrophobic substituting group at the sn-3 position 
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Figure 4-8. Conformational property of 1,2-di-O-palmitoyl-sn-glycerols 
 
Solvent systems: Every compound was dissolved in a homologous medium of CDCl3. In 
the case of the methanesulfonyl derivative (Ms), a mixture of CDCl3 and CD3OD (10:1) 
was also tested to give the result in Ms(2). Abbreviation: Acyl = palmitate (C16), Ms = 
3-O-methanesulfonyl derivative, C16 = 3-O-palmitoyl derivative. 
  
 In solution states as undertaken in the present 1H NMR study, the 
titled 1,2-di-O-palimitoy-sn-glycerols were found to show a conformational 
behavior very similar to each other. The rotamers equilibrium was constant 
among them keeping the approximate ratio of gt (40-45%), gg (40%) and tg 
(20%), (Figure 4-8) When the result of compounds 4 (X=H) is compared 
with those of 5 (X=Ms and Ms(2)) or 6 (X=C16, palmitate), we can know the 
substituent effect by these hydrophobic group at the sn-3 position. These 
hydrophobic groups have induced no apparent change along the tail sn-1,2 
conformation. It is notable that the gauche-conformers (gt and gg) are more 
favored than the trans-conformer (tg). This is consistent in any acyclic 
compounds we gave so far examined and has been rationalized with the 
term of “gauche-effect”.  
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b. Conformational property of GGPL-I and DPPC with a polar 
substituting group at the sn-3 position 
 
The amphiphilic DPPC favors the gt-conformer strongly around the tail 
sn-1,2 position [1 along the C(1)-C2(2) bond] disfavoring the tg-conformer 
in an approximate ratio of gt (60%), gg (35%) and tg (5%, Figure 4-9). The 
difference of DPPC from the previous hydrophobic sn-glycerols is obvious, 
especially in the point that the sn-3 phosphocholine group can induce a 
significant change in the conformational property along the acyclic tail 
moiety. It is notable also that the clockwise helicity is pronounced by the 
increasing gt(+)-conformer versus the anticlockwise gg(-) one along the 
asymmetric 1,2-di-O-acyl-sn-glycerol backbone . 
 
 
 
Figure 4-9. Conformational property of GGPL-I and DPPC 
Solvent systems: A mixture of CDCl3 and CD3OD (10:1). In the case of 
DPPC (2), an alternative solvent system, i.e., a mixture of CDCl3 and 
CD3OD (2:1) was used. 
 
Abbreviations: DPPC = 1,2-O-dipalmitoyl-sn-phosphatidylcholine, 
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GGPL-I: One of major glycolipid antigens of M. fermentans and can be 
characterized by the presence of phosphocholine group at the -Glc-6-OH 
position [22]. 
 
M. fermentans -D-glucopyranosyl-sn-glycerolipids (GGPL-I) showed a 
similar tendency in the conformational property though the increment of 
the gt(+)-conformer was smaller than the case of DPPC. Both DPPPC and 
GGPL-I take the two gauche-conformers near exclusively at the tail 
position. This seems very unique to the amphiphilic 
1,2-di-O-acyl-sn-glycerols and also significant in the event of forming a 
plasma membrane. We have observed also that the GGPL-I head moiety 
around the sn-2,3 position adapts a random conformation taking every gt, 
gg, and tg-conformers in averaged ratio (1:1:1). Probably, these amphiphilic 
chiral sn-glycerols can cooperate well in forming a lamellar structure 
without separating from each other and without giving stereochemical 
stress to each other.  
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c. Conformational property of Mycplasma pneumoniae -MGDG and 
-DGGL 
 
Figure 4-10. Conformational property of Mycplasma pneumoniae -MGDG and 
-DGGL 
 
Solvent systems: For beta- -di-O-palmitoyl-3-O- (-D-glucopyranosyl)- 
sn-glycerol] and its D-galactopyranosyl isomer (beta-MGDG), a mixture of CDCl3    and 
CD3OD (10:1) was used as solvent. For beta-MGDG(2), a mixture of CDCl3 and CD3OD 
(1:1), for beta-DGGL(3), a mixture of CDCl3 and CD3OD (2:1) was used. 
 
Mycoplasma pneumonia possesses mono--Gal glycerolipid (-MGDG 
in Figure 4-10) which serves as a key intermediate for bio-syntheses of 
-DGGLs (-Glc- and -Gal-types, in Figure 4-4). The present study 
examined the conformational property of both -MGDG and -DGGL 
(-Glc-type) and compared their behaviours with DPPC, GGPL-I and its 
synthetic precursor, -GlcDG [24,25].     
    The results in Figure 4-10 indicate that these -Gal glycerolipids tended 
to exclude the trans-conformer (tg) more strongly than GlcDG. In 
comparison with DPPC and GGPL-I (Figure 4-9), they took the 
anticlockwise gg(-) more strongly. This tendency was enhanced in the 
methanol-rich solvent [-MGDG(2)] and also in the M. pneumonia 
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-DGGL. There, time-averaged populations of the three rotamers was 
gt:gg:tg = ca. 50:50:0, indicating that the tail sn-1,2 position adapts the two 
gauche-conformers having a reversing helicity each other. The 
conformational behaviour of MGDG was changed by solvents, and there 
was notable difference in conformational behaviours between-gluco-lipid 
(GlcDG) and the M. pneumonia -glycolipids (-MGDG and -DGGL).  
 
d. Effects of acyl groups and solvents on the conformational property 
along the tail sn-1,2 position 
 
 
Figure 4-11. conformational property of  Phospholipids in different solvents 
 
Solvent systems: A1: CDCl3+CD3OD (10:1), A2: CDCl3+CD3OD (2:1), CD3OD = 
CD3OD (>99.5%), D2O = D2O (>99.5%).  
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    Next, the author wish to discuss on the possible effect of acyl groups by 
referring the NMR data of DPPC and its n-hexanoate (C6) derivative 
(DHPC: 1,2-di-O-hexanoyl-sn-phosphtidyl choline), which were reported by 
Hauser et al [14,15] and analyzed in our way (Figure 4-11). As shown in this 
figure, the basic conformational property of DPPC is affected neither by the 
acyl groups nor by the solvents dissolved. The strong gt(+) and gg(-) 
preference to the tg conformer is not ascribable to a possible hydrophobic 
interaction between the long C16 acyl groups at the tail sn-1,2 position. 
Also strong hydration around the head moiety does not seem to affect the 
conformation property at the tail, and the overall conformation behavior of 
DPPC looks stable under different solvent conditions.  
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Figure 4-12. Conformational property of   M. pneumonia  -Gal-lipids in 
different solvents 
 
Solvent systems: A1: CDCl3+CD3OD (10:1), A2: CDCl3+CD3OD (2:1), A3: CDCl3 and 
CD3OD (1:1), D2O = D2O.  
 
In case of the M. pneumonia -Gal-lipids, acetyl (C2) homologues were 
prepared in our research group (R. Matsunaga, K. Fukuda, H. Dohi & Y. 
Nishida, unpublished result) and listed in Figure 4-12 as beta-Galp (C2) 
and beta-DGGL (C2). These acetyl homologues are of highly utility not only 
in biological studies but also for the present conformational study. This is 
because they are soluble in water. Otherwise, -Gal-lipids can be hardly 
dissolved in aqueous solvents. Therefore, a mixture of chloroform and 
methanol has been generally used as solvent for making solutions of 
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glycolipids, despite these organic solvents are unusual in biological systems.  
    The conformational behavior along the tail sn-1,2 position was very 
stable in the point that the tg conformer was the most disfavored. 
Obviously, the observed gt(+)- and gg(-) preference is not associated with 
hydrophobic interactions, and this result well matched the preceding 
conclusion in the study on the phospholipids. The population of the 
anticlockwise-helical gg(-) tended to decrease, while the tg-conformer 
increased to some extents when the long C16 group was replaced with the 
acetyl group. However, the relative order of gt(+) > gg(-) >> tg was 
maintained among all of the M. pneumonia -Gal lipid homologue 
examined here, and their rotational properties long the sn-1,2 position was 
substantially different from what we have seen in the phospholipid 
homologues in the point that the clockwise-helical gt (+) conformer is more 
strongly favored in the order as gt(+)  >  gg(-) >> tg.  
 
d. Conformational property of M. pneumonia-Gal lipids around the 
head moiety 
 
To elucidate the three dimensional (3D) structures of the M. pneumonia 
Gal lipids (-MGDG and -DGGL), 1H NMR analysis was extended to 
the glycerol sn-2,3 position.  A definitive  assignment was performed for 
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the diastereomeric protons (H-3proR and H-3proS) at the sn-3 position by 
adapting our preceding 1H NMR rule for -(1→6)-linked disaccharides [19]. 
Briefly, the -glycoside linkage at the hexose O-6 position causes a 
significant downfield shift for H-6proS signal (ca. 0.2-0.3 ppm), while the 
-glycoside linkage causes the downfield shift for H6proR signal (ca. 
0.2~0.3 ppm). In the 1H NMR spectrum of 1,2-O-dipalmitoy-sn-glycerol 
(compound 4 in Figures 4-8 and, the two H-3 protons appeared at a region 
very close to each other ( ppm = 3.72~3.73) in a typical AB-X coupling 
pattern. In the -Gal-linkage caused the downfield shift to H-3proS (3.93 
ppm) relative to H-3proR (3.7 ppm) by ca. 0.2 ppm.  Definitive assignment 
was carried out also for the two H-6 protons (H-6proR and H-6proS) of each 
glycoside residue according to our preceding data of (6S)-[6-2H]-D-hexoses 
[20]. Thus, every 1H-signal has been assigned for the conformational analysis 
at the head group in the M. pneumonia -Gal glycerolipids (Tables 4-2 and 
4-3).  
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Table 4-2 Complete 1H-NMR assignments of M. pneumonia -MGDG homologues in 
solution states. 
Com p Solv
sn-Glycerol H1proR H1proS H2 H3proR H3proS
4.18 4.37 5.22 3.69 3.93
6.0 3.1 m 5.7 5.2
11.7 11.7 10.7 10.7
Gal H-1 ' H-2 ' H-3 ' H-4 ' H-5 ' H-6 'proR H-6 'proS
4.19 3.46 3.46 3.83 ca 3.5 ca. 3.7 3.75
7.8 m m br overlap br m
H1proR H1proS H2 H3proR H3proS  (d ppm / J HZ)
4.14 4.27 5.19 3.62 3.85
6.5 3.2 m 6 5.5
12.1 12.1 11 11
Gal H-1 ' H-2 ' H-3 ' H-4 ' H-5 ' H-6 'proR H-6 'proS
4.14 3.4-3.7 3.4-3.7 3.82 3.4-3.7 3.67 3.76
7.5 overlap overlap 0.4 m 5.2 6.5
H1proR H1proS H2 H3proR H3proS
4.18 4.33 5.2 3.7 3.94
6.3 3.4 m 5.5 5.4
11.9 11.9 11.01 11.01
Gal H-1 ' H-2 ' H-3 ' H-4 ' H-5 ' H-6 'proR H-6 'proS
4.19 3.49 3.45 3.83 3.46 3.7 3.75
8.0 10.0 3.0 0.4 bt 5.9,11.0 6.7
the second order analysis 3.7 3.75
5.4 6.6
CDCl3/CD3OD=
１０/1 (v/v)
CDCl3/CD3OD=
1/1 (v/v)
beta-MGDG
(C16)
beta-MGDG
(C2)
1H signals   (Chemical shift ppm /J HZ)
CDCl3/CD3OD=
1/1 (v/v)
 
 
     For the conformational analysis, some of the diastereomeric protons at 
the D-galactose residue appeared in a close region to afford an ABX 
coupling pattern. In this case, chemical shift and coupling constants were 
collected with the second order analysis in an established way.[26] Solvents 
effects were examined for the water soluble -Gal-lipids since it is thought 
that hydration can provide a major factor for determining a conformational 
property of carbohydrate molecules.[27]  
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Table 4-3 Complete 1H-NMR assignment of M. pneumonia -DGGL homologues in 
solution states. 
D2O H1proR H1proS H2 H3proR H3proS
3.49 3.57 3.8 3.65 3.8
6.0 4.0 m m m
12.01 12.01
Gal H-1 ' H-2 ' H-3 ' H-4 ' H-5 ' H-6 'proR H-6 'proS
4.29 3.43 3.54 3.8 3.46 3.68 3.63
8.0 10.0 3.5 0.4 m 9.0, 11.5 4
the second order analysis 3.68 3.64
8.4, 11.6 4
H1proR H1proS H2 H3proR H3proS
4.18 4.35 5.22 3.69 3.91
5.9 3.1 m 5.8 5.5
12.01 12.01 11.01 11.01
Gal H-1 ' H-2 ' H-3 ' H-4 ' H-5 ' H-6 'proR H-6 'proS
4.18 3.48 3.43 3.9 3.62 3.8 3.97
7.7 9.5, 7.7 3.3 3.3 bt 6.2 6.8
10.5
Glc H-1 '' H-2 '' H-3 '' H-4 '' H-5 '' H-6proR'' H-6proS''
4.3 3.19 ca. 3.3 ca. 3.4 ca. 3.5 3.64 3.84
5.4 2
12
H1proR H1proS H2 H3proR H3proS Ac1 Ac2
4.23 4.39 5.25 3.77 3.98 2.09 2.08
6.2 3.4 m 5.5 5.6
12.01 12.01 11.01 11.01
Gal H-1 ' H-2 ' H-3 ' H-4 ' H-5 ' H-6 'proR H-6 'proS
4.24 3.54 3.49 3.94 3.69 3.86 4.02
7.3 7.4, 9.5 3.3, 9.7 3.3 bt 6.4 6.4
Glc H-1 '' H-2 '' H-3 '' H-4 '' H-5 '' H-6proR'' H-6proS''
4.36 3.25 3.4 ~3.34 ~3.34 3.7 3.9
7.9 8.0, 9.0 9.0, 9.0 m 5.5 2
H1proR H1proS H2 H3proR H3proS Ac1 Ac2
4.21 4.3 5.2 ~3.82 ~3.99 2.04 2.02
6.2 3.2 m ~4.9+0.3 6
12.01 12.01 11.5 11.5
Gal H-1 ' H-2 ' H-3 ' H-4 ' H-5 ' H-6 'proR H-6 'proS
4.32 3.42 3.56 3.86 ~3.78 3.82 3.95
7.9 8.0, 9.9 3.3, 10.0 3.3 bdd ~8.0 3.5, 10.6
Glc H-1 '' H-2 '' H-3 '' H-4 '' H-5 '' H-6proR'' H-6proS''
4.43 3.199 3.4 3.9 3.37 3.625 3.83
8.0 8.0,9.0 8.9, 9.0 9.0, 9.0 ddd 6.0, 12.3 2.3
D2O
beta-DGGL
(C16)
CDCl3:CD3OD
= 2/1 (v/v)
beta-DGGL
(Ac)
CDCl3:CD3OD
= 1/1 (v/v)
MGDG-OH
 
 
The conformational behaviour along the sn-2,3 position was compared 
with 1,2-di-O-palmitoyl-sn-glycerol (1,2-di-palmitin in Figure 4-13 or 
compound 4 in Figures 4-7and Scheme 4-1), in which sn-3 OH group is free 
from glycoside linkage. The rotamer distribution along the sn-2,3 bond was 
analogous to the conformation along the tail sn-1,2 position, favouring the 
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two gauche-conformers of gt(+) and gg(-).  
 
 
 
Figure 4-13. Conformational property of compounds above around the head moiety 
 
Solvent systems: A1: CDCl3+CD3OD (10:1), A2: CDCl3+CD3OD (2:1), A3: CDCl3 and 
CD3OD (1:1), CDCl3 = CDCl3 (chloroform-d).  
 
    The observed conformation property was significantly changed when 
the sn-3 OH was modified with glycoside linkage irrespective of - and 
-linkages. The M. fermentans GGPL-I and the relating a-Glc lipid adapt 
the three conformers in an averaged extents, i.e., gt:gg:tg = 1:1:1. It should 
be of high interest to see the trans-tg conformer was favoured in the M. 
pneumonia -Gal lipids. This is because it is widely accepted that 
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gauche-conformers become predominant in these acyclic 1,2-diol organic 
compounds because of “gauche-effects”.  
 It is also known that the gauche-effect is enhanced in polar solvents 
rather than in less polar ones.[2,28,29] Here, the author examined possible 
effect of solvents by using the C2 (Ac) homologues of -MGDG and 
-DGGL, which were soluble in water. The results as shown in Figure 4-16 
have indicated that the C16 and C2 isomers give rise to no significant 
difference in the conformational preference along the head sn-2,3 bond in a 
mixture of CDCl3 and CD3OD (A1~A3), while the conformational 
behaviour changed significantly in water their solutions. There, the 
tg-conformer decreased and the clockwise-helical gt(+) increased. Such a 
change has never been observed along the tail sn-1,2 bond, and this seem 
characteristic to the conformation at the head position in these Gal 
glycerolipids.  
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Figure 4-14.Conformational property of compounds above around the head moiety 
 
Solvent systems: A1: CDCl3+CD3OD (10:1), A2: CDCl3+CD3OD (2:1), A3: CDCl3 and 
CD3OD (1:1), D2O = D2O.  
 
The results in Figure 4-16 showed also that the gt(+)-conformer along 
the sn-2,3 bond increased with the polarity of solvents increased. This 
tendency accorded with the preceding studies regarding the 
“gauche-effects” and may be associated some electron static effect around 
the vicinal oxygen atoms. It is also possible that hydration around the 
sugar surface, which is often called “glyco-layer,” plays a major role in the 
notable conformational change.   
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e. Conformational property of M. pneumonia -Gal lipids around the 
D-galactose C5-C6 bond. 
 
 
 
Figure 4-15. Conformational property of M. pneumonia -Gal lipids around the 
D-galactose C5-C6 bond. 
 
 
 Also D-hexose C5-C6 bond gives rise to three staggering 
conformers. The conformational analysis around the exocyclic 
position has extensively been performed since Nishida et al.[20,30,] 
determined the preferred conformation of monosaccharides in 
solutions with an unequivocal evidence by deuterium labelling 
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and 1H NMR spectroscopic analysis. In this study, the 
conformational property was examined for the M. pneumonia 
-Gal lipids by using the water soluble C2 (Ac) homologues. 
   The analysis was performed in the same way as has just 
been cited above and was based on the 1H NMR data being given 
in Tables 4-2 and 4-3. The prochiral H-6proR and H-6proS 
signals in D-galactose residue were discriminated unequivocally 
with (6S)-[6-2H]-D-galactose derivatives. [31,32]  
 
 
 
Figure 4-16．1H-NMR analysis of the M. pneumonia -DGGL (Glc-type) 
 
   In a mixture of CDCl3 and CD3OD 10:1), the C5-C6 bond 
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favored the tg-conformation, while the conformational 
preference changed into gt(+) in wate solution. The drastic 
change is the same as what we have been in both D-galactose 
and D-GalNAc derivatives. A similar phenomenon was observed 
also in the 1H-NMR analysis of the M. pneumonia -DGGL 
(Glc-type, Figure 4-16). The (1→6)-linkage strongly favored the 
clockwise-helical gt (+) (70%) rather than the other two 
conformers, gg(-) (25%) and tg (5%) in water (D2O) solution.  
The above conformational property has disclosed also such a 
unique 3D-structure of -DGGL (Glc-type), in which the 
terminal D-Glc residue is folded back to the reducing end 
terminal (Figure 18) by adapting the clockwise-helical gt(+) 
conformation around the D-Gal C5-C6 bond.  
 
4-5 Conclusion and Perspectives  
     
   The author has described a conformational analysis for a 
series of Mycoplasma glycolipids, whose absolute structures had 
been elucidated in our research group. M. fermentans GGPLs 
and M. pneumonia -DGGLs. 
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Figure 4-17. Difference in 1H-chemical shift values of MDGD-Ac. 
 
   They have a common conformational property at the acyclic 
glycerol moiety; the lipid tail moiety prefer two 
gauche-conformations (gg and gt) in the order as gt > gg >> tg, 
while the sugar head moiety takes three conformers near 
equally (gg = gt = tg). At the tail position, gt-conformer with 
clock-wise helicity is predominated over anti-clockwise 
gg-conformer. The observed conformation was very close to what 
we have seen in DPPC. The coincidence allows us to assume 
that the Mycoplasma GGPLs may be able to constitute 
cytoplasm membranes in good cooperation with other 
phospholipids without affording any stereochemical stresses.  
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Figure 4-18. A possible role of GGLs in the M. pneumonia cytoplasm 
membrane.Molecular dynamic analysis with NMR spectroscopy supports 
that  M. pneumonia GGLs can make a self-assembled micro-domain (raft) 
in cytoplasm membrane and construct  “hydrophobic lipid pore”  in it.  
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4-6 Experimental section (in preparation) 
 
 General Methods 
    Infrared (IR) spectra were recorded on a JASCO FT/IR-230 Fourier 
transform infrared spectrometer on the form of KBr disks. All 1H NMR 
(500 MHz) spectra were recorded using Varian INOVA-500 or Varian 
Gemini 200. 1H chemical shifts are expressed in parts per million (ppm) 
by using an internal standard of tetramethylsilane (TMS = 0.000 ppm). 
Mass spectra were recorded with a JEOL JMS 700 spectrometer for fast 
atom bombardment (FAB) spectra. Silica gel column chromatography was 
performed on silica gel 60 (Merck 0.063-0.200 mm and 0.040-0.063 mm). 
For purification of synthetic products, a column chromatography on 
Iatrobeads (IATRON LABORATORIES. INC., 6RS-8060) was applied. For 
thin layer chromatography (TLC) analysis, Merck pre-coated TLC plates 
(silica gel 60 F254, layer thickness 0.25mm) and Merck TLC aluminum roles 
(silica gel 60 F254, layer thickness 0.2mm) were used. All other chemicals 
were purchased from Tokyo Kasei Kogyo Co., Ltd., Kishida Chemical Co., 
Ltd., and Sigma - Aldrich Chemical Company Co, Int., and were used 
without further purification. 
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Concluding Remarks 
 
  It is confusing and difficult to identify the 
mycoplasma-infected patient among those of incurable diseases. 
There is no straightforward method that is valid at an early 
stage in infection and appearance of MIDs symptoms. 
Glycolipid-antigen presentation (cellular immunity) specific 
characteristics, it is expected that synthetic lipid-antigens could 
be used as diangostic kits and Vaccines. 
  In chapter 2，the author described a practical synthetic 
pathway to GGPL-I homologue (C16:0) and its diastereomer, in 
which our one-pot -glycosylation method was effectively 
applied. The synthetic GGPL-I isomers were characterized with 
1H NMR spectroscopy to determine equilib ium among the three 
conformers (gg, gt, tg) at the acyclic glycerol moiety. The natural 
GGPL-I isomer was found to prefer gt (54 %) and gg (39 %) 
conformers around the lipid tail, while adopting all of the three 
conformers equally around the sugar position. This property 
was very close to what we have observed in the conformation of 
phosphatidylcholine (DPPC), suggesting that the Mycoplasma 
glycolipids GGPLs may constitute the cytoplasm fluid 
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membrane together with ubiquitous phospholipids without 
inducing stereochemical stress.  
  In Chapter 3, the author  found that effects of  sn-3 
substituting groups are associated closely with the homologous 
solution state in methanol. The obtained effects will be changed 
widely by the solvents used and other surrounding conditions. 
The author recent interests are focused on roles of sn-3 
O-glycosyl groups at the head in 1,2-di-O-acyl-sn-glycerols 
which possess a strong self-assembling property analogously 
phospholipids. Though situations will become more complicated 
than the present case, the approach undertaken here will work 
effectively towards solution of stereochemistry in these 
biomembrane forming 1,2-di-O-acyl-sn-glycerols.  
  In Chapter 4, the author describesd 1H-NMR analysis for a 
series of 1,2-di-O-palmitoyl-sn-glycerols carrying different 
functional groups at the sn-3 position. The functional group 
involved phosphocholine in DPPC and - and β-D-gluco or 
galactopyranosides in M. fermentans GGPL-I and M. 
pneumoniae -DGGLs.  
    In the present NMR analysis, all of the methylene protons, 
i.e, HproR and HproS, at the sn-1 position was assigned 
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unequivocally on the basis of our previous 1H-NMR studies on 
chirally deuterium-labelled sn-glycerols and then used for the 
present conformational analysis. Time-averaged populations of 
three staggered conformers (gg, gt, and tg) were determined 
around the sn-1,2 bond. To examine an effect of acyl groups and 
solvents, we used also some acetyl-homologues in which the 
sn-1,2 palmitate was replaced with acetate (Ac) group.  
The NMR analysis has shown that 1,2-dipalmitoyl- 
sn-glycerols adapt a conformation equilibrium between the two 
gauche-conformers of gt (40-60%) and gg (30-40%) around the 
1,2-diacyl moiety.  
Phospholipids adapted the clockwise-helical gt(+) more 
than the anti-clockwise gg(-) conformer. This tendency was kept 
in the M. fermentans α-glycolipids (GGPL-I) and the relating 
α-glucolipids, supporting our previous conclusion that the M. 
fermentans GGPL-I is able to construct a bio-membrane 
together with ubiquitous phospholipids.  
The conformational property of the M. pneumonia 
-galactolipids (β-DGGL) was apparently different from these 
phospholipids, suggesting that they may make a self-assembled 
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micro-domain being separated from phospholipid-based bilayer 
membranes.  
In water solutions, the M. pneoumoniae β-glycolipids 
showed a drastic change in preferred conformation at the head 
sn-2,3 position  as well as the sugar C5’-C6’ bond. The 
clockwise gt(+)-conformation was strongly preferred (>70%), and 
thus making such an ordered conformation in which a 
continuous hydrophobic region is expanding from the lipid tail 
into the sugar C5’-C6’ terminal.  
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